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Abstract 
 
X-linked myotubular myopathy (XLMTM) is a congenital neuromuscular disorder characterized 
by profound hypotonia and severe skeletal muscle weakness in the affected newborn males. The 
pathology is associated with mutations in the MTM1 gene leading to loss of function of the resulting 
encoded protein, myotubularin. Myotubularin is a phosphoinositol lipid phosphases known to be 
involved in endosome trafficking and membrane remodeling, however, the molecular mechanisms 
underlying myotubular myopathy are not yet clear. 
 
MicroRNAs (miRNAs) are post transcriptional modulators of gene expression and play an 
important role in many developmental processes and diseases. To identify functional miRNA-protein 
networks that may be dysregulated in myotubular myopathy, we performed miRNA as well as mRNA 
expression profiling of skeletal muscle of Mtm1 knockout mice. Bioinformatic analysis and real-time RT-
PCR validation resulted in identification of 12 miRNAs that showed significantly differential expression in 
Mtm1 mice. The functional targets of these miRNAs in myotubular myopathy were identified by a 
combinatorial approach in which computationally predicted targets genes of these 12 miRNAs were 
matched with statistically altered genes obtained by mRNA profiling of skeletal muscle tissues from 
Mtm1 mice.  Ontological classification of target genes revealed genes primarily belonging to skeletal 
muscle development and maintenance, regulation of cell cycle and differentiation of muscle fibers. 
 
Expression analyses of miRNA-target genes identified from this study were also performed 
during earlier developmental time points (2 and 4 weeks) in Mtm1 mice for a better comprehensive 
insight of miRNA-mRNAs in the progression of the disease. We observed that an increase in the severity 
of XLMTM is associated with an increase in the fold change of several miRNAs and their target genes, 
suggesting their crucial role in pathology of myotubular myopathy.  We hope understanding the 
molecular pathways involving these miRNA-mRNA networks, which are disrupted in myotubular 
myopathy, will contribute to uncovering the mechanisms of muscle development and maintenance and 
the development of new therapies for myotubular myopathy. 
 
 
 
 
Resumo 
 Miopatia miotubular associada ao cromossoma X (XLMTM) é  a forma mais severa de um grupo 
de doenças musculares congénitas denominado miopatias centronucleares.   XLMTM é caracterizada 
por uma marcada  redução de tónus muscular e profunda debilitação do músculo esquelético em 
neonatais do sexo masculino. Como consequência, a maioria dos doentes falece nos primeiros oito 
meses de vida, devido a insuficiência respiratória. XLMTM tem uma estimada incidência de 1:50.000 
neonatais, estando associada a mutações no gene MTM1 que conduzem à perda de função da proteina 
por este codificado, miotubularina. A miotubularina é o membro prototipico de uma família 
evolucionariamente conservada de fosfatases de fosfatidilinositois (PtdIns), envolvida na regulação de 
tráfico endossomal e remodelação membranar. As vias bioquímicas reguladas por miotubularina estão 
fundadamente reconhecidas, no entanto o modo como a deficiência em miotubularina e 
consequentemente uma alteração nos níveis de  fosfatidilinositol 3-P e fosfatidilinosital (3,5)P2 
conduzem a um fenótipo musculo-esqueletico especifico é ainda indeterminado.  
 Estudos recentes atribuem à miotubularina um papel crucial no manutenção dos tubulos 
transversais (tubulos T). Os túbulos T são parte integral das triadas que constituem a região subcelular 
responsável pelo mecanismo de excitação e contração muscular. Os túbulos T são estruturas 
membranes que requerem constantes oscilações dos níveis de PtdIns, regulados por miotubularina. 
Segundo este modelo,  uma deficiência em miotubularina conduz a uma descoordenação dos 
mecanismos de contração muscular, resultando na atrofia muscular observada nos doentes de miopatia 
miotubular.  
 Neste projecto pretendemos clarificar as vias afectadas pela ausência de miotubularina e 
compreender o envolvimento dos microRNAs na patofiosiologia da miopatia miotubular. Os microRNAs 
(miRNAs) são moléculas recentemente descobertas que modulam a expressão génica a nível pos-
transcripcional.  Após transcrição, transporte para o citoplasma e vários ciclos de processamento 
mediados pelas RNAses III Drosha e Dicer, os miRNAs funcionam como moléculas guia, que reconhecem 
por complementaridade as regiões 3’UTR dos mRNA alvo e promovem o seu silenciamento. Elevados 
graus de complementaridade miRNA:mRNA geram  degradação do mRNA alvo enquanto que ligações 
com mismatch conduzem a repressão da tradução. A importância dos microRNAs no desenvolvimento 
muscular e em estados patológicos foi previamente demonstrada através da formação de Dicer 
knockouts condicionais e reportada em várias doenças neuromusculares. 
 Com o intuito de identificar potenciais vias reguladas por microRNAs alteradas na miopatia 
miotubular uma abordagem baseada em microarrays foi adoptada. O perfil de expressão de miRNAs e 
mRNAs foi primariamente efectuado e potenciais interações miRNA-target identificadas. miRNA 
profilling e subsequente validação por real time PCR revelaram expressão diferencial de miRNAs em 
ratinhos deficientes em miotubularina quando comparados com os controlos, demonstrando o seu 
envolvimento na miopatia miotubular. Na tentativa de decifrar redes miRNA/mRNA alvo relevantes para 
o desenvolvimento de XLMTM, o perfil de expressão de mRNAs foi comparado com a lista de potenciais 
alvos dos microRNAs obtidos como significantes nesta experiência por abordagens bioinformaticas. A 
combinação dos resultados de mRNA profiling (com 424 genes significantes) para a identificação de 
potenciais alvos dos 12 microRNAs obtidos como significantes nas análises de miRNA microarrays 
resultou em 142 genes alvos diretos de microRNAs.  Este grupo de genes potencialmente regulados por 
miRNAs e diferencialmente expressos no contexto da patologia foram subsequentemente classificados 
em grupos funcionais sobre-representados usando o software GOstat. As categorias funcionais de 
contração muscular, regulação da progressão através do ciclo celular, morfogénese do músculo 
cardíaco, assim como desenvolvimento do músculo esquelético e componentes do sarcomero foram 
identificadas.  
 Dada a relevância biológica dos grupos funcionais obtidos, estudos posteriores basearam-se em 
genes presentes nestas categorias. Apenas genes que apresentaram um padrão de expressão diferencial 
contrário ao dos seus potenciais miRNAs foram considerados uma vez que os microRNAs regulam 
negativamente a expressão dos seus mRNAs alvo. Subsequente validação da expressão dos genes 
selecionados por qRT-PCR array permitiu a formulação de hipóteses quanto às vias moleculares 
envolvidas na XLMTM.  
 Estes estudos permitiram verificar que a atrofia muscular observada em pacientes de miopatia 
miotubular é dependente da expressão de FoxO1/Murf1/Mafbx. FoxO1 é um membro crucial da via de 
sinalização celular Akt/Pi3k que conduz a atrofia muscular como resposta a uma redução da actividade 
desta via. FoxO1 promove um aumento de expressão de componentes chave da via de ubiquitinacao-
proteossoma. Em particular, Murf1 e Mafbx (moléculas sobreexpressas em XLMTM como foi detectado 
por análises de microarrays)  foram identificados como marcadores necessários para a activação de 
atrofia muscular. Igualmente várias proteínas integrais do sarcomero previamente reportadas como 
envolvidas no processo de atrofia muscular foram encontradas sobre-expressas e potencialmente alvo 
de miRNAs sub-expressos na miopatia miotubular.  
 Estes resultados sugerem que estes miRNAs possam talvez não ter um papel específico nesta 
patologia, mas representar um mecanismo de regulação comum a outras doenças musculares. Desta 
forma, usando adenovirus para sobre-expressar estes miRNAs (sub-expressos em condições de atrofia 
muscular) poderá ser possível reduzir os níveis de proteínas implicadas no processo de atrofia e 
consequentemente atenuar o progresso da miopatia miotubular, entre outras doenças musculares. 
Adicionalmente foi também observada uma persistente sub-expressão de microRNAs alvo de genes 
inibidores de proliferação celular e respectiva sobre-expressão dos respectivos mRNA. Entre este os 
genes supressores de tumores p21, Gadd45a e Dusp4 representam alvos candidatos de microRNAs sub-
expressos nesta doença. Igualmente, marcadores de diferenciação celular foram consistentemente 
detectados sobre-expressos.  
 Por outro lado, foi observado um aumento de expressão de genes (regulados por miRNAs) 
envolvidos no controlo da manutenção da população de células estaminais em ratinhos mutantes para 
miotubularina. Estas observações despoletaram o desenvolvimento de hipóteses explicativas da 
incapacidade do músculo esquelético de responder a estímulos regenerativos. É postulado que a 
incapacidade do músculo de ratinhos mutantes de promover hipertrofia muscular poderá estar 
correlacionada com um defeito no potencial proliferativo das células estaminais. De uma forma 
cooperativa vários miRNAs pertencentes a um mesmo cluster genomico (Dlk1-Dio3 cluster no 
cromossoma 12 em Mus musculus) poderão ser responsáveis pela sobre-expressão de genes inibidores 
do ciclo celular e igualmente genes indutores da diferenciação celular.  
 Estas evidências sugerem que uma redução na capacidade de proliferação celular acoplada a um 
aumento de proteinas de diferenciação nos ratinhos knockout deficientes em miotubularina, resultam 
na produção de apenas um pequeno pool de satellite cells activadas (células estaminais progenitoras de 
tecido muscular), insuficientes para uma eficiente reparação da injuria muscular. Esta incapacidade 
regenerativa  poderá ser um dos mecanismos básicos fundamentais a contribuir para o desenvolvimento 
de atrofia muscular.  Os genes responsáveis por estas duas vias (activação das células estaminais 
precursoras de mioblastos e indução de atrofia muscular) são regulados por vários microRNAs que 
formam uma rede altamente coordenada levando a que mesmo um pequeno defeito no circuito resulte 
no desenvolvimento de severa atrofia, incluindo associada às manifestações de miopatia miotubular.  
 Estudos de expressão génica realizados para diferentes tempos de desenvolvimento do ratinho 
usando a tecnologia de highthroughput qRT-PCR array permitiram demonstrar a relevancia do grupo de 
genes regulados por miRNAs selecionados. 26 genes envolvidos nas vias de diferenciação/proliferação 
de células estaminais ou proteinas marcadores de atrofia muscular foram testados e demonstraram 
significativas alterações de expressao entre as classes wild-type e KO ratinhos ainda no estado pré-
clinico da doenca. Desta forma, a hipotese de estas moléculas representarem apenas  representarem 
um artefacto experimental ou apenas serem inespecificamente induzidas como consequência do estado 
geral de doença foi refutada. Os microRNAs encontrados diferencialmente expressos na XLMTM e 
identificados como responsáveis pelo estabelecimento de várias das vias funcionais desreguladas neste 
sistema constituem candidatos preferenciais para estudos futuros de terapia genética.  
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1) Introduction 
1.1) Linked Myotubular Myopathy 
 linked myotubular myopathy (XLMTM) is the most severe form of a group of congenital 
muscular disorders named centronuclear myopathies, and presents an estimated incidence of 1 in 
50,000 newborn males. (D'Amico and Bertini, 2008) In contrast to the heterogeneous patterns 
found in the majority of congenital myopathies, XLMTM has a relatively homogeneous clinical 
presentation, where males are born with marked hypotonia and generalized muscle weakness, 
with respiratory difficulties often requiring ventilation. Most XLMTM patients die within 4-8 
months as a consequence of respiratory failure. Even though some of them are able to survive 
several years (approximately 15%), and some achieving independent respiration, so far, it is not 
possible to accurately predict the severity of the phenotype at birth. (Jungbluth et al., 2008) 
 The morphological hallmark in muscle biopsies of XLMTM patients is the presence of 
numerous rounded hypotrophic fibers with a higher than expected occurrence of centrally placed 
nuclei in hematoxylin/eosin stained sections. This pattern resembles the structure of fetal 
myotubes, whereas in healthy individuals nuclei usually occupy a peripheral location. The 
percentage of these “myotubes” in a sample can vary widely among cases with a reported range 
between 2% to 60%. Based on this canonical characteristic this pathology previously was thought 
to be due to an arrest in muscle development at the myotube stage. (Sarnat, 1990) Subsequent 
studies, however, refuted this hypothesis and suggested instead that myotubular myopathy 
represents a defect in skeletal muscle maintenance. Typically found surrounding these nuclei in 
central locations is a clear perinuclear zone containing glycogen and mitochondria deposits, which 
can be observed in histochemical stains PAS and NADH-TR, respectively. (Tronchere et al., 2003) 
Disease diagnostic results from an integrative approach compiling pathological findings, 
age of onset and, if available, genetic testing. The definitive diagnosis, however, is based on 
genetic screening for mutations in the MTM1, the only gene associated with the development of 
the pathology. (Laporte et al., 1996) So far, more than 200 different loss-of-function mutations 
have been identified throughout the entire coding sequence of MTM1, in more than 300 unrelated 
families. (Laporte et al., 2000) The MTM1 gene spans approximately 100Kb at the genomic level, 
contains 15 exons and is located in Xq28 locus. MTM1 mRNA is expressed as of 3.9 Kb long 
transcript, ubiquitously expressed in all human tissues as idenfied by northern blot analysis. 
Interestingly, in skeletal muscle and testis, an additional smaller 2.5 Kb tissue-specific transcript is 
detected, resulting from the use of a different polyadenylation site. The biological significance of 
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this mechanism of gene regulation for MTM1 remains unknown, pointing out the importance of 
further studies in MTM1 expression control. (Pierson et al., 2005) 
 
1.2) Myotubularin and the etiology of myotubular myopathy 
The protein product of the ubiquitously expressed MTM1 gene is myotubularin, a 
phosphatidylinositol (PtdIns) lipid phosphatase of 603 amino acids. Myotubularin contains an 
active phosphatase domain (PTP) and a prixomal PH-GRAM domain that binds phosphoinositides. 
Phosphoinositides (PI) are lipid second messengers that play key roles in signal transduction, 
trafficking and cellular homeostasis through the recruitment of effectors proteins to their 
subcellular target sites. The selection of the PI specie to be formed (in a set of seven) is dependent 
on the phosphorylation/ desphosphorylation balance in the position 3, 4 or 5 of their inositol sugar 
rings. These interconversions are controlled by their respective PI kinases and phosphatases. 
Myotubularins are 3’-phosphatases specific for PtdIns3P and PtdIns(3,5)P2, PIs involved in the 
endosomal–lysosomal pathway. (Robinson and Dixon, 2006) 
Myotubularin is the archetypical member of a protein tyrosine phosphatase (PTP) 
superfamily of 14 closely related genes that share high levels of homology, present in a wide 
spectrum of eukaryotic organisms from yeast to mammals. (Clague and Lorenzo, 2005) In the 
myotubularin family only 8 members were defined has containing phosphatase activity. Other 
myotubularins that have an inactive phosphatase seems to be crucial for the stability and 
activation of the other catalytic active members. Most of the myotubularin family members are 
able to form homodimers or heterodimers with other members of the family by direct protein-
protein interactions. The interaction between the inactive MTMR9 and active MTMR6 form 
reflects this essential function by leading to an increase in the 3-phosphatase activity of MTMR6 
up to 6-fold. (Zou et al., 2009) Mutations in MTMR13 or its binding partner MTMR2 have been 
found in human patients of Charcot-Marie-Tooth disease further strengthing the importance of 
their interactions. 
The biochemical functions of myotubularin have been intensively described, although, the 
biological pathways and regulatory mechanisms that when disrupted lead to myotubular 
myopathy, still remain uncertain. To address these questions several knockout/overexpression 
experiments were recently developed. Using siRNA-mediated technology it was demonstrated 
that knocking down the levels of myotubularin results in an increase of 60% to 120% of 
endogenous PI3K that accumulates on early endosomes. The sequential waves of PI(3)P synthesis 
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and degradation, regulated by the interplay of PI3 kinases and phosphatases and controlled by the 
activation of Rab GTPases, has been postulated to be the mechanism for signal transduction and 
receptor sorting necessary for acute recruitment, release or activation of the trafficking machinery 
components, during endocytosis. (Cao et al., 2008) A dysregulation in the orchestration of these 
antagonistic proteins seems to lead to impairment cellular metabolism, contributing to the 
development of several pathologies, including XLMTM.  
Likewise MTM1, several MTM related genes (MTMR) have been established as involved in 
different types of neuromuscular disorders (e.g. MTMR2 and MTMR13 mutations are associated 
with Charcot-Marie-Tooth type 4B1 and 4B2 neuropathy, MTMR14 mutations result in autosomal 
centronuclear myopathy, MTMR1 splicing variants are associated with myotonic dystrophy and 
MIP/Mtmr14 mutations lead to muscular weakness and fatigue). (Azzedine et al., 2003); (Houlden 
et al., 2001); (Shen et al., 2009) 
It is remarkable to note that ubiquitously expressed PI phosphatases acting in the same 
biological pathway and with similar catalytic active profiles are involved in pathologies affecting 
different specific tissues. As noted above, MTMR2 gene that shares 65% sequence identity with 
MTM1 affects primarily Schwann cells in peripheral nerves instead of skeletal muscle as MTM1 
mutations. The reason for large amounts of apparently functional redundant PI proteins seems to 
be directly correlated with their specific spatiotemporal expression pattern and subcellular 
location. Both MTM1 and MTMR2 desphosphorylate pools of Ptdns(3)P and Ptdns(3,5)2P, 
however, MTM1 primary acts both on early and late endosomes, whereas MTMR2 is exclusively 
active on late endosomes. (Nicot and Laporte, 2008) 
Although displaying specific subcellular functions, at least some MTM-related genes are 
able to compensate for the lack of expression of a particular family member, demonstrating a fine 
efficient mechanism of gene regulation, to restore cell homeostasis. MTM1 is ubiquitously 
expressed, although XLMTM is a muscle specific disorder. A possible justification for this 
phenomenon is the ability of MTMR1 and MTMR2 to compensate the loss of myotubularin in all 
but skeletal muscle tissue, where MTM1 is the main 3’-phosphatase. (Dowling et al., 2009) 
The overexpression of myotubularin promotes formation of fillapodia-like structures and 
disrupts protein transport from late endosomes to lysosomes. (Tsujita et al., 2004) To deeper 
define the subcellular function of myotubularin in skeletal muscle, overexpression experiments 
were performed using adeno-associated virus (AAV) vectors expressing myotubularin. The 
formation of packed membrane assemblies and the presence of vacuoles positives for T-tubules 
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and plasma membrane markers were observed. Subcellular staining of myotubularin revealed the 
protein associates with sarcolemma and triads. Triads are highly specialized junctions where the 
control of calcium concentration, and therefore, regulation of excitation-contraction occurs. These 
structures are constituted by transverse T-tubules (plasma membrane invaginations) and terminal 
cisternae of sarcoplasmic reticulum.  Myotubularin is suggested to be important for the 
maintenance of triads, remodeling of longitudinal T-tubules to become transverse T-tubules and 
plasma membrane homeostasis. The failure of these processes would lead to impaired excitation-
contraction coupling and consequently generate muscular atrophy. (Buj-Bello et al., 2008); (Al-
Qusairi et al., 2009) 
In vivo studies using morpholino antisense technology to knockdown myotubularin, 
provides additional functional evidences supporting this hypothesis. Knockdown of myotubularin 
in zebrafish results in impaired motor function and histopathologic changes in skeletal muscle, 
resembling clinical XLMTM patient observations. Also, tubule-reticular structural abnormalities 
were found in MTM1-morpholino treated zebrafish and human patient biopsies, displaying 
disorganized and irregular patterns. T-tubule integrity is required for proper force generation, 
muscle contraction and more specifically for the process of excitation-contraction coupling. 
Defects in T-tubule structure and localization (T-tubule were found concentrated around the 
abnormal located nuclei in XLMTM patients) were also associated with T-tubule functional defects, 
as was demonstrated by abnormal mechanisms of excitation-contraction observed in skeletal 
muscle. (Dowling et al., 2009) 
The physiological implications of T-tubules dysfunction in the etiology on myotubular 
myopathy can be hypothesized: T-tubules are membrane invaginations whose biogenesis and 
maintenance requires continuous recycling of membrane components, including 
phosphoinositides. If MTM1 function is disrupted, membrane recycling does not occur efficiently. 
Consequently, T-tubule function is impaired, leading to abnormal excitation-contraction 
mechanism, necessary to produce muscle force. Mutations of MTM1, causing loss of function, 
deregulate this process, and subsequently promote muscle wasting and atrophy, characteristics 
present in skeletal muscle of myotubular myopathy patients. (Dowling et al., 2009) 
Recent findings, originated through investigation of MIP/MTMR14 mutant mice, 
remarkably elucidate the crucial function of MTMR14 in control of PtdInsP levels in establishing 
calcium homeostasis and muscle performance. Several PtdInsP were identified to directly bind and 
activate ryanodine receptors (RyR1) - the skeletal muscle calcium release channel in sarcoplasmic 
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reticulum, crucial for excitation-contraction coupling. These studies strongly help to understand 
how loss of myotubularin family proteins that are responsible for regulation of PtdInsP function 
lead to muscle contraction deficiencies. (Shen et al., 2009) (Treves et al., 2005) 
Although considerable progress has been made in the understanding the pathogenesis of 
XLMTM, many critical aspects still remain mainly uncovered, in particular concerning the 
translation of the identified metabolic defects, into the skeletal muscle phenotype found in the 
disease.  
In this project we will try to bring new insights to address these questions by studying 
gene expression control in the myotubularin-deficient mouse, model of XLMTM, using microarray 
analysis of mRNA as well as miRNA (endogenous modulators of gene expression) expression 
profiles. We aim to contribute to dissect primary molecular pathways disrupted in myotubular 
myopathy through the identification of miRNA-mRNA regulatory interactions and differential 
expression of relevant genes in the context of the disease, in knockout mice when compared to 
wild-type littermates. 
 
1.3) Skeletal muscle development 
The knowledge of the networks underlying muscle development and the regulatory 
mechanisms responsible for the homeostasis and maintenance of muscle integrity are a pivotal 
basis of muscle biology we hope to improve with our findings. 
Skeletal muscle results from muscle progenitor cells derived from mesoderm. In humans, 
at approximately 3 weeks of gestation, these muscle stem cells generate myoblasts which fuse to 
generate myotubes at 7 weeks. The myotube stage is characterized by long multinucleated 
filaments with central located nuclei sharing the same basal lamina. Along the development, 
myotubes start to produce significant amounts of contractile components required for muscular 
function. Also, each nucleus acquires an individual basal lamina and become innervated. At this 
step, mature myotubes are called myofibers and possess peripheral located nuclei and contractile 
apparatus located in the central region. The determination of cell fate and coordination to 
myogenic lineage specific seems to be upstream regulated by Pax3 and Pax7. (Maroto et al., 1997) 
(Seale et al., 2000) Pax3 acts mainly during primary myogenesis while Pax7 during the later stages 
of muscle growth.  
After the initial phase of embryonic muscle development, muscle mass can be produced, 
according to functional needs, by mechanisms such as hypertrophy (the most common adult 
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muscle growth) and hyperplasia (primary occurs during embryonic development). During skeletal 
muscle growth through hypertrophy, myofibers increase their volume by increasing the amount of 
contractile components, requiring the incorporation of additional nuclei. Satellite cells are 
mononucleated cells able to fuse and increase the growing capacity of myofibers. (Sanger, 2004) 
  Satellite cells are the major muscle precursor cells and are involved in maintenance and 
repair of skeletal muscle. These stem cell-like structures derive from the dermomyotomal 
population (the dorsal compartment of the somites, where the embryonic myogenesis starts to 
take place), located in a specific niche between the basal lamina and the sarcolemma. Typically, 
there is a small pool of mitotically quiescent satellite cellswhich are activated in response to 
external stimuli that produce stress such as need for growth by hypertrophy or muscular injuries. 
Activated satellite cells proliferate and generate myogenic precursor cells (myoblasts), which 
undergo multiple rounds of cell division until they experience terminal differentiation. The 
resulting cells undergo fusion, leading to the formation of multinucleated myofibers.  
 The molecular mechanisms that underlie the regulation of the satellite cell pool and their 
self-renewal are still poorly understood.  Myogenesis requires co-expression of myogenic 
regulatory factors (MRFs) such as Myf5, MyoD, Myogenin and MRF4 which promote cell cycle 
arrest and subsequent terminal differentiation into contractile muscle fibers. Concomitant with 
this process is the down-regulation of the levels of pax7. (Buckingham and Montarras, 2008) 
Several studies indicated pax7 as a key molecule in adult muscle cell remodeling pointing out its 
action as a negative regulator of MyoD and Myogenin and consequently delaying the successful 
adoption of the myotube phenotype. It has also been recently elucidated that myostatin controls 
self-renewal of satellite cells and their state of activation, through negative regulation of pax7 via 
the Erk1/2 pathway. (Bryson-Richardson and Currie, 2008; McFarlane et al., 2008) 
Skeletal muscle development is organized by evolutionarily conserved networks of 
transcription factors that coordinate the expression of muscle-specific genes responsible for 
muscle growth, differentiation and contractibility. MADS-box transcription factors MEF2 (myocyte 
enhancer factor 2) and SRF (serum response factor), in combination with MyoD and Myogenin 
(basic helix-loop-helix factors) play a central role in the regulation of myogenesis through the 
activation of fine subsets of muscle specific genes according to developmental stages. (Chen et al., 
2009) 
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1.4) microRNAs biogenesis and cellular function 
 
Recently, an additional layer of complexity in skeletal muscle gene regulatory circuits 
started to be revealed.  MicroRNAs (miRNAs) are pos-transcriptional gene expression modulators. 
Through their ability to coordinately regulate networks of genes, they enable a fast and precise 
cellular reaction to developmental, physiologic and pathologic signals in skeletal muscles. 
(Williams et al., 2009) 
The recognition of fundamental catalytic activities carried out by RNA molecules on gene 
expression dates back to 1961 when Jacob and Monod proposed the role of RNAs in the inhibition 
of operons expression, through Watson-Crick base-pairing interactions with the operator 
sequence. (Jacob and Monod, 1961) However, the steeply growing knowledge and interest about 
these tiny molecules was triggered by the discovery of RNA interference mechanism in 1998 by 
Craig Mello’s group. (Fire et al., 1998) By silencing the expression of specific genes in specific 
spatial-temporal limits this phenomenon of gene silencing generated by small non-coding RNAs 
(and effector proteins) is implicated in innumerous crucial cellular and biological processes and 
has been associated with human pathologies.  MicroRNAs are defined as ssRNAs of ~22 
nucleotides in length generated by the RNAse-III enzyme Dicer from an endogenous transcript 
containing a local hairpin structure. (Ambros et al., 2003) Bioinformatics methodologies have 
predicted that almost 30% of mammalian mRNAs of protein coding genes are regulated by these 
molecules, revealing their remarkable biological significance. (Bartel, 2004) 
The first experiments highlighting the existence of miRNAs were conducted by the Ambros 
and Ruvkun labs. It was reported that short lin-4 RNA directly down-regulate lin-14 gene product 
by binding to specific repetitive sequences on the 3’UTR of the lin-14 messenger. This functional 
interaction promotes the progression from the first nematode larval stage to the second. (Lee et 
al., 1993) (Wightman et al., 1993) 
Despite the fact that it is only seven years the next miRNA was discovered (let-7) (Reinhart 
et al., 2000) at the date of writing, the official miRNA database - miRBase (release 14.0, Sep 2009) - 
reports 10581 mature miRNAs in 115 species, including more than 700 human miRNAs. 
(http://www.mirbase.org) For a long period of time, miRNAs were thought exclusive to 
multicellular organisms, as a vehicle for the transition to a more complex organism design. Recent 
studies have identified microRNAs in Chlamidomonas reinhardtii, a unicellular alga, demonstrating 
the evolutionarily conserved nature of this mechanism of gene regulation. (Molnar et al., 2007) 
Masters dissertation/ The role of microRNAs in X-Linked Myotubular Myopathy 
Mariana Fontes 
Universidade de Lisboa – Faculdade de Ciências 8 
With only one unique exception detected so far (Bao et al., 2004) microRNAs function at 
the post-transcriptional level. MicroRNAs regulate gene expression either by blocking mRNA 
translation or decreasing mRNA stability in the cytoplasm. New perspectives expect microRNAs to 
operate in almost every cellular process, including regulating pre-mRNA processing in the nucleus, 
acting as chaperones that modify mRNA structure or modulating mRNA-protein interactions. 
(Filipowicz et al., 2008) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The genomic localization and transcription process used for microRNAs is not deeply 
understood yet, however, different mechanisms seem to be involved. Initial studies have pointed 
out that the majority of microRNAs were encoded in intergenic regions (> 1kB away from the 
annotated/predicted gene) although the presence of microRNA codified in intronic regions in the 
Figure 1: Schematic representation of 
miRNAs biogenesis and their mode of action. 
(Filipowicz, 2008)  
miRNAs can either be transcribed as 
independent transcriptional units producing pri-
miRNAs or as a result of splicing of intronic 
portions of protein-coding genes (mirtrons) 
leading to the direct formation of pre-mRNAs . 
Pri-miRNAs are processed by a complex that 
includes Drosha giving rise to pre-miRNAs.  
These molecules are transported to the 
cytoplasm through exportin5 and cleaved by the 
RNAse III type Dicer to yield approximately 20 
nucleotide miRNA duplexes. One of the strands is 
selected to form the mature miRNA being 
assembled into a miRNA-induced silencing 
complex (miRNP) while the other strand is 
subsequently degraded.  High levels of 
complementarity between miRNA:mRNA target 
lead to endonucleolytic cleavage and sequences 
with several mismatches guide translational 
repression of mRNA targets. 
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sense or antisense orientation were quickly reported: the notion of microRNAs as autonomous 
transcription units had emerged. Since more than 50% of the miRNAs are in close proximity with 
each other, and it was experimentally proven that they can be transcribed by their own promoters 
as a unique unit of clusters of pri-miRNAs, there is sufficient data to demonstrate that microRNAs 
might be transcribed as mono or polycistronic transcription units.  
Their biogenesis is usually catalyzed in two major steps, processed by two RNAse III family 
proteins, namely Drosha and Dicer. (Figure 1) Once the precursors miRNAs (pri-miRNAs) are 
transcribed, typically by RNA Pol II (besides some exceptions reported (Cai et al., 2004)) they fold 
in a long hairpin-like structure containing an imperfectly base-pairing stem, often including several 
sequences for different miRNAs. Pri-miRNAs are processed by the endonuclease Drosha, 
complexed with a dsRNA-binding protein DiGeorge syndrome critical region gene 8 (DGCR8), 
leading to the release of ~70 nucleotide hairpins known as pre-miRNAs. As an RNAse III 
endonuclease, this enzyme cuts the RNA duplex at both strands of the stem near the base of the 
primary stem loop, resulting in a stem with 5’ phosphate and 2 nucleotides 3’ overhang. An 
alternative pathway that circumvents the requirement of Drosha-DGCR8 machinery was found in 
C. elegans, D. melanogaster and mammals and enable a subset of pre-miRNAs (mirtrons) to be 
generated from introns, by cooperative actions of spliceosome and lariat-debranching enzyme 
(LDBR). (Berezikov et al., 2007; Ruby et al., 2007) 
In animals the pre-miRNAs are actively transported to the cytoplasm by the nuclear 
transport receptor exportin-5, in a cooperative complex with Ran-GTP, which after hydrolysis 
permits the release of the cargo. Once there, pre-miRNAs are subsequently subject to the second 
processing step by Dicer (associated with TAR RNA binding protein), generating the final ~22 
nucleotides miRNA duplex product. This short duplex is incorporated into the functional miRNA-
Ribonucleoprotein complex (miRNP), where the mature miRNA preferentially remains assembled 
in the complex.  
The criterion for the selection of the strand to be matured seems to be the 
thermodynamic stability of the 5’ end, with the less stable end to be generally elected and the 
other degraded. The key components of miRNP or miRISC (microRNA- induced silencing complex) 
are the Argonaute family proteins (AGO). This family comprises four AGO proteins with only AGO2 
protein having the ability to participate in the RNAi-like mechanism developed by this complex. 
After assembly, the mature miRNA strand functions as the guide molecule to the complementary 
mRNA target to be silenced. The recognition of the exact mRNA to be targeted seems to be the 
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more controversial and critical issue in understanding the function of microRNAs in mammals. In 
plants the interactions between microRNA:mRNA are nearly perfect but when this relation is 
transposed to metazoans, miRNAs usually bind to mRNA by imperfect base-pairing, yielding 
variable degrees of miRNA-target mismatches.  Consequently, this leads to large difficulties in the 
prediction of their target mRNAs. (Winter et al., 2009) 
 Although the mechanistic details of this interaction are poorly understood it is accepted 
that a stringent requirement must be present for a functional and productive binding: a 
contiguous and perfect base-pairing on the 2-8 nucleotides of the 5’end of the miRNA with the 
mRNA, denominated seed region. (Lewis et al., 2005) Further studies have also mentioned the 
importance of secondary structures on the 3’ untranslated region (UTR) surrounding the target 
site (seed) in the target mRNA and the ability of complementarity at the 3’ end of the cognate 
miRNA to compensate for imperfect seed matching. (Brennecke et al., 2005) 
 The molecular basis of this interaction is directly correlated with the selected 
pathway in miRNA-mediated gene regulation. If miRNA:mRNA-target interaction presents high 
affinity and nearly perfect complementary, the mRNP complex will trigger endonucleolytic mRNA 
cleavage by an RNAi-like process. On the other hand, when this match is imperfect, the most 
common event in mammals, miRNA lead to translation repression and possibly destabilization of 
the mRNA target. (Carthew and Sontheimer, 2009) 
Despite the consensus about the role of microRNAs in promoting translation repression of 
mRNA targets, the mechanism through which miRNAs interfere with active translation, and, in 
particular, the step of translation inhibited, is a matter of controversy.  Perhaps, the paramount 
open question is if miRNAs modulate gene expression by single or multiple mechanisms. Thus far, 
the model of miRNA gene regulation interfering with translation initiation stage has received 
increasing support by in vivo and in vitro studies. However, repression mechanisms starting after 
the initiation of translation mediated by miRNAs were also identified when miRNAs were found 
associated with actively translating polysomes. (Filipowicz et al., 2008) 
miRNA regulatory pathways can not only affect the translation  of cognate mRNAs but also 
might directly decrease their amounts, through the promotion of molecule destabilization.  
miRNAs control transcript levels by recruiting the machinery involved in mRNA decay. miRNPs 
recruit GW182  (a protein of the P-body structure), which subsequently recruits proteins involved 
in 3’ poly-A cleaving. As a result, an unstable transcript is generated, susceptible to 3’-5’ 
exonucleotidic activity, and vulnerable to decapping proteins with subsequent 5’-3’ exonucleases 
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exposure. (Behm-Ansmant et al., 2006) P-bodies are highly dynamic cytoplasmatic structures, 
enriched in translation repressor molecules and mRNA-catabolizing enzymes. By conducting mRNA 
targets to P-bodies, miRNAs can promote the cleavage or storage of the repressed mRNAs, making 
miRNA regulation a versatile and wide ranging system. (Rana, 2007) 
Furthermore, Vasudevan and colleagues have illustrated this versatility when they 
reported that miRNAs complexed with Ago2 and FXR1 (Fragile X mental retardation protein 1) can 
trigger upregulation of mRNAs target, in specific cellular conditions.  MicroRNAs can switch from 
repression to activation according to cell cycle state: in proliferating mammalian cells they repress 
translation whereas in G1/G0 arrest, which usually precedes differentiation, they can potentially 
promote activation of gene expression. (Vasudevan et al., 2007) 
As trans-acting molecules, miRNAs act in the maintenance of cellular homeostasis and 
development in cooperation with transcription factors. It is now clear that miRNAs have highly cell 
type-specific expression profiles and mutations in specific miRNAs that lead to the development of 
severe diseases.  
 
1.5) miRNAs in skeletal muscle 
The importance of the role of miRNAs in skeletal muscle development was identified 
through the generation of conditional Dicer null alleles under the control of MyoD regulatory 
elements (a muscle specific marker). The resulting Dicer-deficient mice show skeletal muscle 
hypoplasia associated with perinatal lethality. C2C12 experiments demonstrate increased 
apoptosis of cultured embryonic myoblasts. (O'Rourke et al., 2007) 
Further studies revealed the involvement of particular muscle specific miRNAs (MyomiRs) 
in skeletal muscle proliferation and differentiation. (Chen et al., 2009; Williams et al., 2009) miR-1 
and miR-206 were identified as enhancers of myogenesis and mir-133 was ascribed as a critical 
factor for myoblast proliferation and repression of myoblast differentiation. miR-1 promotes 
muscle cell differentiation by  targeting histone deacetylase 4 (hdac4). Hdac4 is a main repressor 
of Mef2c, which in turn constitutes an essential muscle related transcription factor. Besides 
belonging to the same miRNA polycistron and being transcribed together, mir-133 triggers an 
opposite effect to mir-1. miR-133 stimulates myocyte proliferation, to a certain extent, by 
reducing the levels of serum response factor (SRF), a crucial regulator of muscle cell differentiation  
(Chen et al., 2006) Similarly to mir-1, mir-206 promotes myoblast differentiation. miR-206 has 
been shown to inhibit electrical coupling between myofibers via gap junctions through the 
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suppression of gap-junction protein connexin 43 (Cx43), a required step after fusion of skeletal 
myoblast during myogenesis (Anderson et al., 2006) Also, mir-206 is responsible for the 
suppression of cell proliferation by the repression of p180 subunit of DNA polymerase-alpha and 
inhibition of genes encoding follistatin-like 1 and utrophin in skeletal muscle. (Kim et al., 2006); 
(Rosenberg et al., 2006) 
A surprising evidence of the connection of miRNAs to skeletal muscle disorders came from 
a direct genetic link, observed in a Texel sheep detected with exceptional muscularity. Fine 
mapping identified a mutation in the 3´-UTR of the myostatin gene (GDF8), a transforming growth 
factor family B (TGF-B) member, responsible for inhibition of muscle growth. This mutation creates 
an illegitimate microRNA target site for miR-1 and miR-206, muscle-specific miRNAs, that lead to 
specific translation repression of myostatin, and consequently promote muscular hypertrophy. 
(Clop et al., 2006) 
As of late, miRNA overexpression or downregulation was associated with several primary 
muscular disorders, including muscular dystrophy and nemaline myopathy, contributing to 
progress in the understanding of these pathologies. (Eisenberg et al., 2007) Nevertheless, these 
studies have not been conducted for X-linked myotubular myopathy.  
 
1.6) Mouse model of XLMTM 
Given that XLMTM is a rare disorder, we decided to use a knockout mouse (KO) model, 
which reproduces the major features of the human disease, to facilitate sample collection and 
improve statistical relevance. The knockout mouse Mtm14 was generated for Mtm1, through 
homologous recombination followed by selection of mice with exon 4germline excision, by 
Professor Jean-Louis Mandel´s group. This excision causes absence of myotubularin protein 
production by creating a frameshift mutation that induces an early codon stop. Despite this 
deletion generating myotubularin-deficient viable mice, some degree of pre or neonatal lethality 
was observed with only 16.6% of the litter born, instead of the 25% expected. The resulting male 
mice recapitulate the histopathology of human XLMTM, showing morphological variation in 
muscle fiber size and accentuated hypotrophy (predominantly in type 1 fibers), with centrally 
located nuclei present in a higher proportion in the affected animals. A perinuclear halo containing 
ER glycogen and mitochondria accumulations was also detected, as well as myofibrillar 
disorganization with sarcomeric disarray and Z-line streaming.  In accordance with the observed 
pathology in humans, Mtm14 mice manifest a muscle-specific disorder. These data corroborate 
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the tissue specific impact of myotubularin dysfunction in muscle integrity and the inability of other 
MTMRs to compensate for this defect in muscle. (Buj-Bello et al., 2002) 
Although this model reproduces the human disease, some clinical differences are found 
and consequently should be considered when extrapolating conclusions. Mtm1 KO mice present 
with variable and progressive muscular weakness with associated severe reduced life expectancy 
following four characterized stages, based on distinctive clinical manifestations. Mtm1 (-/-) mice are 
born asymptomatic (phase I) manifesting a disease onset around 4-5 weeks of life with 
accentuated decrease in muscular hindlimb strength (phase II) that reaches forelimbs at 5~7 
weeks and is associated with the manifestation of kyphosis (phase III). A reduction of 64% in 
muscle strength is observed in the later phase IV and leads to complete hindlimb paralysis in 
addition to severe respiratory difficulties that often result in cachexia and respiratory insufficiency, 
promoting death at 59  19 days. The human disease is mainly nonprogressive, contrasting with 
the clinical evolution reported in the knockout. Different times of myogenesis may be the reason 
for these discrepancies since mouse muscle differentiation is completed much later during 
development (at birth) as compared with humans (which ends around 16 weeks of gestation). 
Analysis of Mtm1-deficient mice enabled identification of muscle weakness in XLMTM as a 
consequence of atrophy rather than hypoplasia, as well as demonstrated that the observed 
muscle fiber defects are not due to an arrest in myogenesis, but perhaps attributable instead to a 
defect in the maintenance of muscle structure. (Buj-Bello et al., 2002) 
 
1.7) Study description and biological impact 
To decipher the molecular mechanisms underlying XLMTM, it is crucial to improve the 
knowledge about MTM1 gene regulation expression, and in particular, the process involved in its 
translation. In this project we will try to develop new insights about gene expression control in 
XLMTM by bioinformatic analysis of mRNA as well as miRNA expression profiles, using qRT-PCR for 
confirmation of obtained data. 
 Gene expression profiles of XLMTM patients were previously investigated by Nishino 
group. (Noguchi et al., 2005) Using custom cDNA microarrays, the molecular signature of eight 
XLMTM patients was characterized. An upregulation of extracellular/sarcolemmal proteins and 
cytoskeletal components was observed (in particular, actin-interacting proteins). On the other 
hand, proteins involved in muscle contraction and energy metabolism were found downregulated. 
These findings implicate myotubularin as a key regulator of membranous cytoskeletal actin 
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remodeling and suggest that a defect in myotubularin function contributes to disorganization of 
actin filament architecture, giving rise to the characteristic phenotype of XLMTM myofibers, with 
altered cell morphology and abnormal intracellular organelle distribution. (Noguchi et al., 2005)  
 Although the study was the first of its kind aimed at the understanding of the 
pathomechanisms of myotubular myopathy, the project was performed using a custom cDNA 
microarray with only 4,200 selected genes – muscle specific genes and others expected to be part 
of the dysregulated pathways in XLMTM.  Furthermore, the patient group consisted primarily of 
infants was not well matched in age with the controls who were significantly older. 
 In the current investigation we developed a microarray-based approach, using 
oligonucleotide microarrays able to detect whole mice transcriptome, for an unbiased study of the 
molecular mechanisms involved in myotubular myopathy. Also, in a combinatorial methodology 
we analyzed simultaneous significant changes in mRNA and miRNA expression to recognize 
potential miRNA-based regulatory circuits in myotubular myopathy. mRNA and miRNA profiling by 
microarrays were evaluated in endstage mice (7 weeks), given that this is the mouse 
developmental disease time point that better recapitulated human pathology. However, for an 
accurate extrapolation of conclusions to human disease, final significant results should be 
experimentally repeated for confirmation in human skeletal muscle biopsies. Additionally, for a 
deeper understanding of the relevance of statistically significant identified miRNAs in the disease 
context, we analyzed the expression levels of these miRNAs and also several of their candidate 
cognate target genes, by qRT-PCR in two other developmental stages (14 and 27 days mice).  
Through the study of differential regulated pathways in myotubular myopathy, as well as 
the identification of specific miRNAs potentially responsible for the development of the disease, 
we hope to dissect fundamental molecular features of disease and open new avenues for the 
generation of new therapies. The identification of miRNA signatures in diseases and their specific 
characteristics, such as small size and ability to affect the expression of several genes present in a 
given pathway, makes miRNA targeting a promising approach for pathology treatment. New 
approaches, such as locked nucleic acids (LNAs) and antagomiRs, which are synthetic 
complementary sequences able to inhibit the function of miRNAs, represent exciting new 
potential therapies to be used when a particular miRNA is upregulated and identified as promoter 
of a disease phenotype. Adeno-associated viruses (AAV) represent a very efficient delivery method 
to introduce miRNAs into cells of patients where these molecules are downregulated, potentially 
restoring health status.  (Brown and Naldini, 2009); (Eisenberg et al., 2009); (Saunders and Lim, 
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2009) Thus, the findings achieved in this investigation constitute a comprehensive foundation for 
future research into microRNAs-mediated gene regulation in X-linked myotubular myopathy.  
 
2) Methods 
 
2.1) Samples preparation 
Gastrocnemeus muscle from 14, 27 and 49 days mice were dissected under Rnase free 
conditions and immediately frozen using dry ice. Eight samples from 7 week-old wild-type (WT) 
mice and Mtm1 KO mice (Mtm14) were collected for microarray expression profiling.  Four WT 
and four 4 week old mice, as well as 4 WT and 4 KO 2 week old mice gastrocnemeus samples were 
used for additional qRT-PCR experiments. All the protocols for mice experimentation were 
performed in compliance with IACUC (Institute of animal care and use committee) guidelines.  
 
2.2) RNA extraction 
 Total RNA was isolated using mirVana isolation kit (Ambion, Austin, TX) accordingly to 
manufacturer´s instructions. The extraction was made according to the manufacturer’s 
instructions. Yield and purity of RNA was examined using ND1000 Nanodrop (NanoDrop 
Technologies) and 2100 Bioanalyzer (Agilent Technologies).  
 
2.3) miRNA Array analysis 
 miRNA profilling was performed by Asuragen Services (Austin, TX)  applying a custom-
manufactured Affymetrix® GeneChip from Ambion – DiscovArrayTM. RNA samples were processed 
according to the standard operating procedures of the company. (Shingara J, 2005) The miRNA-
enriched fraction was obtained by total RNA fractionation through a flashPAGE Fractionator 
apparatus (Ambion) followed by clean-up and concentration using the flashPAGE Reaction Clean-
Up Kit (Ambion). Subsequently, the resulted purified fraction was hybridized to the miRNA 
DiscovArray containing 623 human and 361 mouse probes plus additional species and >12,000 
exploratory probes. GenePix 4200AL scanner (Molecular Devices) was used to scan processed 
arrays. Microarray signal processing included substraction of estimated background levels based 
on the median signal of a set of G-C-matched anti-genomic controls.  
 Raw data was also normalized through variance stabilization and normalization (VSN) 
method by Asuragen services. For each mature miRNA sequence a minimum of at least two 
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probes were available. After data processing, Asuragen designated the two probes as A and B, 
according to their hybridization performance and signal quality. Only probes A values were 
selected for subsequent statistical analyses.   
 
2.4) mRNA microarray hybridization 
 mRNA expression profiles of Mtm1 KO mice and controls were evaluated by hybridization 
of the isolated total RNA with GeneChip® Mouse Gene 1.0 ST Arrays (Affymetrix) containing 
approximately 27 probes for each of the 28,853 genes, covering the whole mouse transcriptome. 
The chip was processed by the Microarray Core Facility at Children’s Hospital Boston, MA, 
according to the company standard protocol.  Raw data was also further normalized using the VSN 
method using GeneSpring software. 
 
2.5) Principal Component Analysis (PCA), Box-Whisker plot and Hierarchical Clustering 
 PCA was constructed using normalized scaling and mean centered values. Box whisker plot 
was created based on Pearson correlation. Hierarchical unsupervised 2D-clustering was processed 
for non-averaged significant entity lists on WT/MTM1 conditions via Euclidean distance metric and 
average linkage. GeneSpring GX 10.0.2 allowed these analyses.  
 
2.6) Statistical Analysis of microarray data 
 For statistical analysis a combinatorial strategy was used. miRNAs were only considered 
statistical significant if both GeneSpring statistics and SAM identified the same miRNA as 
significant.   
GeneSpring GX was used to apply the non-parametric unpaired Mann-Whitney U test with a cut-
off p-value<0.05. The resulted mRNAs were subject to a filter of fold change> 1.5 and the genes 
still present in the final list considered significant by this statistic approach. In parallel the 
additional Statistical Analysis of Microarrays (SAM) method was also run. A False Discovery Rate 
(FDR) of 18% combined with a bootstrap of 5000 randomization of samples was selected to test T-
statistic.  
 miRNAs matching both statistical criteria detected on GeneSpring and SAM analyses were 
selected for further research.  
 
 
Masters dissertation/ The role of microRNAs in X-Linked Myotubular Myopathy 
Mariana Fontes 
Universidade de Lisboa – Faculdade de Ciências 17 
2.7) miRNA and mRNA Real Time PCR (qRT-PCR) 
 miRNA and mRNA expression were independently assed by real time PCR, using Taqman 
microRNA assays (containing specific primers to generate miRNA cDNA) and Taqman mRNA 
expression assays respectively (Applied Biosystems, Foster City, CA).  
 miRNA expression was evaluated using 5ng of initial RNA sample  and 3 replicates per 
sample in a 7300 ABI Real Time PCR system. The relative amount of each miRNA was normalized 
to snRNA U6 endogenous control and the fold change calculated as described by the equation       
2-ΔΔCt, where ΔΔCt = (CtWt miRNA - CtWt U6) – (CtKO miRNA – CtKO U6).  
 mRNA expression was quantified by qRT-PCR using 48.48 Dynamic array (BioMark System, 
Foster City, CA). For each sample 3 technical replicates were examined with 100 ng of initial RNA 
sample used. Gapdh was select as the endogenous control and similarly fold change calculated 
accordingly to the 2-ΔΔCt  method.  
 
2.8) miRNA target prediction and functional analysis 
 To predict miRNA target genes a multi-step sequential approach was performed.  
 The list of significant miRNAs obtained from the match of SAM and Genespring analysis 
was individually searched against the Argonaute database to identify already described and 
validated mRNA targets of the miRNAs in the study. (http://www.ma.uni-
heidelberg.de/apps/zmf/argonaute/) The previously described miRNA targets found in this 
database were compared with the experimental mRNA expression profiles. Only mRNAs with 
differential expression were considered as potential miRNA target genes.  
 Statistically significantly changed miRNAs were subjected to in silico target prediction 
using the public TargetScan 4.2 algorithm incorporated in the GeneSpring software. 
(http://www.targetscan.org) Matching of subset gene lists obtained for statistically significant 
miRNAs predicted genes and mRNAs profiled by microarrays allowed the identification of most 
probable functional miRNA:mRNA interactions. Predicted genes, that didn´t show an inverse 
differential expression when compared with their associated miRNAs, were excluded from the 
group of genes of interest. 
  Genes targeted by several miRNAs differentially expressed in miRNA microarray analysis 
and overrepresented in significant functional categories were preferentially kept for further 
research. 
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 To characterize gene ontology categories overrepresented in the knockout mouse model 
of XLMTM, GOstat software associated with the MGI (mouse genome informatics) GO database 
was used. The minimum of 3 genes per functional class and an associated p-value<0.02 were used 
as inclusion criteria. (http://gostat.wehi.edu.au) (Beissbarth and Speed, 2004) 
 The precise genomic location and nucleotide sequence of each miRNA was determined 
using miRBase (Wellcome Trust Sanger Institute; http://microrna.sanger.ac.uk). miRBase and 
BLAST allowed search for evolutionary conservation of microRNAs 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). (Griffiths-Jones et al., 2006) 
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3) Results/Discussion 
In this work we have used a genome wide microarray based approach to identify miRNA-
mediated regulatory networks in XLMTM. miRNA expression profile was evaluated using a Mtm1 
mouse model to assess miRNAs potentially contributing to myotubular myopathy. In parallel, 
transcriptional profiles were generated to investigate the occurrence of miRNA/predicted target 
mRNA pairs anti-correlations. The resultant subset of target genes and associated enriched 
pathways might represent significant miRNA-regulated circuits in the pathophysiology of 
myotubular myopathy.  
 
3.1) miRNAs are differentially expressed in XLMTM 
In an attempt to identify miRNAs expression changes in myotubular myopathy, microarray 
experiments were performed for 8 Mtm1 (49 days) mice as well as 8 age-matched WT control 
mice using Affymetrix DiscoVarry chips. These chips were based on miRBase 9.2 that contained 
>13000 miRNAs and representated by all miRBase organisms including Mus musculus (mmu) and 
Homo sapiens. In our studies, only results of hybridization of RNA samples with mmu probes were 
considered for analysis. Each miRNA was represented by two probes on the chip and depending on 
the efficiency of hybridization, they were classified in to two groups: A and B.  Among these two 
groups, probes A (108 miRNAs) provided superior reliability and were further used for data 
analysis by Genespring Software. 
Quality control analyses were done to identify potential outliers among 8 Mtm1 and 8 WT 
control samples by performing Principal Component Analysis (PCA) and Pearson Correlation. All 
samples showed a good correlation by these approaches except two control samples: WT2 and 
WT5. Moreover, these two samples also showed showed a distinct pattern of expression when 
compared with the other samples of the same class by Hierarchical classification so were further 
excluded from the experiment. (Appendix Fig.1 and Fig.2) 
After removing the outlier samples, the 3D-PCA aggregated samples in two different 
clusters which corresponding to two conditions in this study:  Mtm1 mice and WT control muscle 
groups.  The clear separation of muscle samples in two different classes on PCA plot illustrated the 
unique miRNA expression profile in myotubular myopathy disease vs normal condition. (Fig.2) 
These samples were then normalized using variance stabilization method. Normalized 
samples were analyzed by a box whisker plot to compare homogeneity among all samples.  In each 
box plot, the box represents the main body of the data and the whiskers show the extreme values. 
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The variability is indicated by the size of the box and the length of the whiskers. A box whisker plot 
of all normalized samples showed a low variability among them suggesting high quality of 
hybridization data. (Fig. 2) 
 
 
 
 
 
 
Different kind of test statistics may be applied to microarray data. All of these tests are 
aimed at identifying p-values that help assess the likelihood that particular genes are regulated. 
Tests may be parametric or nonparametric. Parametric tests are applied to data sets that are 
assumed to follow a normal (Gaussian) distribution. Common parametric test for comparing two 
groups includes the t-test. Nonparametic tests do not make assumptions about the distribution of 
data. They rank the outcome variable (gene expression) from low to high and analyze the ranks. 
Mann-Whiteny and Wilcoxon tests are the most commonly used among nonparametric tests.   
We analyzed our miRNA microarray data using both parametric as well as nonparametric 
statistical analysis methods to improve the confidence of obtained results. Only those miRNAs that 
were identified as significant in both methods were selected for further experimental validations. 
In nonparametric statistical analysis, GeneSpring GX software (version 10.0.2, Agilent 
Technologies) was employed to perform the Mann-Whitney test using a cut-off p-value<0.05.  In 
parametric analysis SAM was used to perform t-statistics test with a FDR threshold of 18% to 
minimize the number of false positives. A high FDR value was selected to avoid exclusion of true 
Figure 2: miRNA microarray data analysis for endstage mice. a) 3D-PCA analysis shows a robust distinction 
of the two classes (WT and KO) and reveals small variance intra-populations. b) Box Whisker Plot reflects a 
consistent homogeneity of the samples after normalization, as it is illustrated by the predominance of the 
values around 0. 
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hits (Appendix Fig.3). A filter of fold change >1.5 was applied to the subset of list of significant 
results in both statistical methods.  
27 miRNAs were obtained as significant in SAM and 16 miRNAs were identified using 
Genespring. 12 miRNAs matched both lists and therefore were chosen for subsequently studies 
(miR-127; miR-137; miR-337; miR-376a; miR-376c; miR-379; miR-434-3p; miR-434-5p; miR-410; 
miR-431; miR-489 and miR-541). (Table 1) 
 
 
 
 
 
 
           
A hierarchical 2D-clustering constructed for these 12 statistically significant miRNAs using 
the Euclidean measure enabled to additionally investigate the clustering of the distinct patterns of 
expression of both groups. In agreement with the PCA comparison, the heatmap assorts miRNAs in 
mainly up or downregulated in knockout mice versus wild-type animals. Despite this observation, 
three mutant samples (MTM1-3, MTM1-5 and MTM1-8) showed an intermediate level of 
expression being separated from the remaining mutated samples on the clustering tree. (Fig.3) 
 
 
 
Upregulated 
miRNAs
q-value (%)
Downregulated 
miRNAs
q-value (%)
Upregulated 
miRNAs
p-value
Downregulated 
miRNAs
p-value
mmu-miR-137 17,97 mmu-miR-434-5p 0 mmu-miR-137
0,0201
mmu-miR-127
0,002
mmu-miR-324-5p 17,97 mmu-miR-127 0 mmu-miR-329 0,010
mmu-miR-469 17,97 mmu-miR-376a 0 mmu-miR-337 0,020
mmu-miR-546 17,97 mmu-miR-541 0 mmu-miR-376a 0,020
mmu-miR-429 17,97 mmu-miR-434-3p 0 mmu-miR-376c 0,020
mmu-miR-344 17,97 mmu-miR-410 0 mmu-miR-379 0,002
mmu-miR-290 17,97 mmu-miR-431 8,66 mmu-miR-410 0,028
mmu-miR-367 17,97 mmu-miR-379 8,66 mmu-miR-411 0,010
mmu-miR-542-5p 17,97 mmu-miR-383 8,66 mmu-miR-431 0,039
mmu-miR-199b 17,97 mmu-miR-337 8,66 mmu-miR-434-3p 0,002
mmu-miR-465 17,97 mmu-miR-489 12,6 mmu-miR-434-5p 0,002
mmu-miR-464 17,97 mmu-miR-376c 12,6 mmu-miR-466 0,020
mmu-miR-295 17,97 mmu-miR-483 0,010
mmu-miR-224 17,97 mmu-miR-489 0,028
mmu-let-7d 17,97 mmu-miR-541 0,005
SAM GeneSpring statistical Analysis
Table 1: Genespring and SAM results of miRNA microarrays data analysis for endstage mice. miRNAs highlighted in 
green were identified as significant using both statistical methods. 
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3.2) Validation of differentially expressed miRNAs by qRT-PCR analysis 
  
To validate the results obtained in microarray data analysis, qRT-PCR experiments were 
developed for 12 significantlly altered miRNAs identified from the match between SAM and 
statistical analysis using GeneSpring GX. (Table 2) All tested miRNAs, with the exception of miR-
489, showed a good correlation between  microarray and qRT-PCR results. (Figure 4) miR-24 and 
snRNA U6 were tested to use as internal control miRNAs. miR-24 showed significant up-regulation 
in mutants demonstrating not to be an appropriate reference miRNA for skeletal muscle 
expression experiments.  snRNA U6 expression levels in mutant and control samples were 
indistinguishable. Thus, snRNA U6 was adopted for data normalization in qRT-PCR experiments.  
 To check the accuracy of our hypothesis that only those miRNAs  that are common 
between two statistical analysis are significant, we also performed RT-PCR on  few miRNAs that 
were excluded by parametric test, but considered significant by nonparametric and vice versa. No 
significant expression differences were observed for mir-411 (fold difference: significant by 
nonparametric) or miR-295 (fold difference: only identified as significant in parametric) between 
WT and Mtm1 KO samples, corroborating the efficiency of the approach applied. 
Figure 3: Hierarchical 2D-clustering produced for non-averaged significant miRNA lists via Euclidean distance metric 
and average linkage. The miRNA clustering tree is shown on the left and the sample clustering tree is shown on the 
top. The colored range represents the differential expression of miRNAs with red denoting <0 and blue >0.  
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3.3) miRNAs genomic location  
 Several miRNAs identified in our study showed to be arranged in a tandem called Dlkq-
Dio3 cluster array resulted from the processing of a single transcript designated Mirg (microRNAs-
containing gene). Mirg is located in the Dlk1-Dio3 (Delta-like 1 homolog-type III iodothyronine 
deiodinase) imprinted domain in the distal portion of mouse chromosome 12 and respective 
human 14q32, and contains more than 40 miRNAs. (Table 3) (da Rocha et al., 2008)  
 Microarrays qRT-PCR 
mmu-miR-127 -3.09 -2.1 
mmu-mir-137 1.75 2.36 
mmu-miR-337 -3.27 -2.87 
mmu-miR-376a -6.89 -5.5 
mmu-miR-376c -3.16 -1.35 
mmu-miR-379 -2.53 -1.4 
mmu-miR-410 -5.62 -2 
mmu-miR-431 -7.53 -3.4 
mmu-miR-434-3p -2.68 -2 
mmu-miR-434-5p -4.88 -2.01 
mmu-miR-489 -4.39 -9.6 
mmu-miR-541 -5.53 -4.4 
Table 2: Foldchange values obtained for microarray and qRT-PCR of 12 significant miRNAs p-value < 0.05  
and FDR <18% was applied to Genespring and SAM analysis,respectively.   
 
Figure 4: Linear correlation graph 
obtained with microarrays data in the 
X-axis and qRT-PCR values in the Y-
axis for endstage mice.   
Linear Trendline was applied. With 
the exception of miR-489, all miRNAs 
show a directly proportional variation 
of folchange between microarray and 
qRT-PCR values.  
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 miR-431, miR-127, miR-434, miR-379, miR-337, miR-541, miR-410, mir-376a, differentially 
expressed in our miRNA microarray, are located in this cluster. (Appendix Fig.4) miRNAs clustering 
is thought to represent a coordinated internal strategy to control more rapidly and efficiently 
common downstream pathways. Given that the same mRNA is often required to be target by 
several miRNAs, the expression of miRNAs regulated by the by same promoter sequence enables a 
powerful modulation of protein networks in response to a given stimulate. (Yuan et al., 2009) 
(Altuvia et al., 2005) 
 The biological importance of this domain, with ten genes detected so far, is illustrated by 
the resulted phenotypes obtained in Dlk1-Dio3 mutants. (Hagan et al., 2009) A single nucleotide 
mutation in Dlk1-Dio3 domain is responsible for the development of callipyge phenotype in sheep, 
characterized by extreme postnatal muscular hypertrophy, due to upregulation of Dlk1 and Rtl1 
transcripts from this cluster. (Charlier et al., 2001) (Fleming-Waddell et al., 2009) Moreover, Dlk1 
was reported to be involved in regulation of cell fate determination and skeletal muscle 
remodelling, showing high expression levels during development and on satellite cells in 
myopathic conditions. (Andersen et al., 2009) 
 Additionally, it was demonstrated the expression of Dlk1-Dio3 cluster requires Mef2 
(myocyte enhancing factor 2) transcription factor activation in neurons. (Fiore et al., 2009) Mef2 is 
also a regulator of myogenesis, responsible for the coordination of muscle specific gene 
expression in developing embryos. These evidences suggest the potential induction and 
implication of this cluster in myogenenesis. Mirg expression (containing several microRNAs 
differentially regulated in this experiment) was never reported in skeletal muscle and mir-410 and 
miR-431 were identified as nervous system specific. (Wheeler et al., 2006) In this study we report 
for the first time the expression of miRNAs belonging to Dlk1-Dio3 domain in skeletal muscle of 
mice with 14, 27 and 49 days. The reason underling the non-detection of these miRNAs in previous 
experiments might correlate with the fact in situ analyses were developed for embryonic day 11.5. 
Primary mouse myogenesis starts between E12.5 and E14.5 and secondary fibers start to be 
established around E14-E16. (Buckingham et al., 2003) Further functional experiments, using in 
situ hybridization, should also be performed in adult mice sections to an accurate understanding 
of temporal expression patterns of identified differential expressed miRNAs. 
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miR-489 is an intronic miRNA located in the host gene calcineurin receptor precursor (CT-R) 
 miRNAs expression often correlates with expression of their respective host genes as well 
they involved in common biological pathways. In this study all miRNAs, with the exception of miR-
489, are located either in the Dlk1-Dio3 cluster or in intergenic regions widespread in the genome. 
Interestingly, the host gene of miR-489 is the calcineurin-receptor precursor.  
 In adult animals, muscle growth is mainly mediated by hypertrophy, resulting in an 
increase in size, rather than in number, of pre-existing muscle fibers. Depending on 
external/internal stimulus, different molecular signaling pathways can be activated to increase 
intracellular Ca2+ levels, which subsequently promote not only muscle contractibility but also the 
induction of muscle specific genes required for hyperthrophy. Insulin-like growth factor (IGF-1) 
expression, mediated by the activation of phosphoinositide 3-kinase (Pi3K)/Akt/mTOR and 
PI(3)K/Akt/GSK3 pathways, is thought to be sufficient to induce hypertrophy. (Rommel C, 2001) 
However, Ca2+/calmodulin-dependent pathway, through the activation of calcineurin and 
subsequent interaction with GATA2 and NFATc1, was also reported to be required, although not 
sufficient, for hypertrophic mechanisms. (Musaro et al., 1999) (Semsarian et al., 1999) 
Calcineurin is a Ca2+/calmodulin-activated phosphatase implicated in the phosphorilation 
state of NFAT (nuclear factor of activated T cell) transcription factor members. Calcineurin enables 
the activation and subsequent nuclei translocation of specific NFAT isoforms, which in cooperation 
with MEF2, are crucial in the modulation of muscle specific gene expression in different stages of 
skeletal muscle development. (Schulz and Yutzey, 2004) A direct role of calcineurin in myoblast 
differentiation was also observed in C2C12 myogenic cells. Calcineurin levels were demonstrated 
to be upregulated during terminal myogenesis, with the inhibition of calcineurin being responsible 
for a decrease myoblast ability to progress to myotube formation stage. (Delling et al., 2000) 
Moreover, calcineurin signaling appears to be crucial in reprogramming of myofiber-
specific gene expression, promoting the transition from resting IIb fiber types to slow contractile 
type I fibers (muscle fibers able to sustain high concentrations of intracellular calcium as a result of 
tonic motor nerve activity). (Naya et al., 2000) (Chin et al., 1998) 
In this project it was not observed a significant change in the expression levels of 
calcineurin, however calmodulin levels were found to be downregulated. In several neuromuscular 
disorders, and mainly in congenital myopathies, higher incidence of atrophy in type I (slow) muscle 
fibers is mainly observed. (Imoto and Nonaka, 2001) In myotubular myopathy this phenomenon is 
not a constant observation, however type I predominance is often detected. (Pierson et al., 2005) 
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3.4) Biological relevance of identified miRNAs 
 
Significant miRNAs involved in cell-cycle arrest and progression to differentiation state 
 It is noteworthy the observation that several miRNAs found differentially expressed in this 
study were consistently reported as cell cycle regulators in previous investigations. (Table 4) 
 miR-137, in cooperation with miR-124, was identified in glioblastoma multiforme tumors 
to inhibit cellular proliferation. Furthermore, it was revealed miR-137 induces differentiation of 
mouse neural stem cells. (Papagiannakopoulos and Kosik, 2008; Silber et al., 2008) 
 Conversely, miR-489 was found to be down-regulated upon differentiation and when 
inhibited promote differentiation of human mesenchymal stem cells - progenitor cells with multi-
lineage capacity that can generate myocytes. (Schoolmeesters et al., 2009) 
 Despite different results were obtained for different tumors miR-127 was also 
associated with the modulation of cell cycle. In invasive squamous cell carcinomas patients, this 
microRNA was upregulated (suggesting the role in the promotion of proliferation). Also, it was 
identified as a potential biomarker for lymph nodes metastasis in this condition. (Lee et al., 2008) 
In contrast with these studies, in hepatocellular carcinoma miR-127 was shown to be 
downregulated in the early stages of the disease in a rat model. (Tryndyak et al., 2009) 
In our data, miR-137 is overexpressed, while miR-127 and mi-489 are downregulated in 
the later, most severe stage of the disease. Overall, we might speculate the process of myogenesis 
miRNA ID 
Chromosome 
location 
Genomic region Gene description  
mmu-miR-137 chr 3 Intergenic region   
mmu-miR-337 chr 12 Intergenic region   
mmu-miR-127 chr 12 Rtl1  Retrotransposon-like protein 1  
mmu-miR-376a chr 12 Intergenic region   
mmu-miR-376c chr 12 Intergenic region   
mmu-miR-379 chr 12 Intergenic region   
mmu-miR-410 chr 12 Intergenic region   
mmu-miR-431 chr 12 Rtl1  Retrotransposon-like protein 1  
mmu-miR-434-3p chr 12 Rtl1  Retrotransposon-like protein 1  
mmu-miR-434-5p chr 12 Rtl1  Retrotransposon-like protein 1 
mmu-miR-489 chr 6 Calcr Calcitonin receptor Precursor 
mmu-miR-541 chr 12 Intergenic region   
Table 3:  Significant miRNAs identified by bioinformatic analysis and their genomic location in mouse. The data below 
was obtained from miRBase (miRNA database). 
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is being promoted while proliferation supressed, with miRNAs reported to trigger differentiation 
upregulated (miR-137) and miRNAs responsible to suppress this process downregulated (miR-489, 
miR-127) in endstage Mtm1-deficient mice.  
 
 
 
3.5) miRNAs expression differences during mouse development 
   
 Subsequently to the identification of statistical significant miRNAs by bioinformatic 
analysis of microarrays and their experimental validation by qRT-PCR we decided to assess their 
differential expression in two additional developmental time points. Through an integrative 
analysis of miRNA differential expression changes in 14, 27 and 49 days mutant animals, compared 
to respective controls, we aimed to deeper understand the role of selected miRNAs in the 
progression of myotubular myopathy severity. 
 Real-time PCR experiments detected the expression of all 12 tested miRNAs in skeletal 
muscle of 14, 27 and 49 days mice. (Figure 5) Comparing to endstage (49 days) mice which 
manifest significant levels of identified miRNAs downregulation, 14 and 27 days mice only present 
slight expression changes in KO/WT analysis.  A pattern of increasing or decreasing foldchange 
sequentially from 14 days to 27 and finally 49 days, was not observed for miR-127, miR-376a, miR-
376c, miR-379, miR-410, miR-431 and miR-434-3p. These results might indicate that the function 
of specified miRNAs is only triggered and biologically relevant in the most severe stage of the 
disorder. Conversely, miR-337, miR-434-5p, miR-489 and miR-541 show a significant progressive 
decrease in foldchange (KO/WT) values from the assymptomatic stage of the disorder (14 days 
Genomic location miRNA name Cellular function 
Cluster Dlk1-Dio3 
 miR-337, miR-376a, miR-376c, miR-
379, miR-410, miR-431, miR-434-3p,              
miR-434-5p, miR-541 
Cooperative role regulated by MEF2;   
Induction of myogenesis? 
miR-127 Cell cycle regulator 
Intergenic and 
intronic region 
miR-137  
Inhibition of proliferation and 
induction of differentiation 
miR-489 Induction of stem cells differentiation 
Table 4: Previously described functions of 12 identified miRNAs  
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mice) to their terminal most severe stage (endstage 49 days mice). Based on these evidences we 
suggest a direct involvement of these microRNAs in the evolution and associated increase in 
phenotypic severity of myotubular myopathy. Finally, we highlight miR-137 and miR-489 for 
presenting a constant pattern of up and downregulation in mutants, respectively, throughout 
mouse development. miR-137 and miR-489 might represent main fundamental miRNAs essential 
for the etiology and manifestation of XLMTM.  
 
 
 
 
 
 
3.6) mRNA expression profile of XLMTM 
  
 Following the identification of 12 differentially expressed miRNAs for subsequent in silico 
target prediction, we further restrict our analysis to mRNAs statistically differentially expressed in 
myotubular myopathy to increase the biological relevance of this study. Affymetrix Exon 1.0 ST 
array was used for mRNA hybridization that contains 27 probes for each of the approximately 
-11.0
-9.0
-7.0
-5.0
-3.0
-1.0
1.0
3.0
5.0
14 days mice
27 days mice
49 days mice
Fold Change
(KO vs WT)
Figure 5: qRT-PCR foldchanges values for KO/WT 14 days, 27 days and 49 days mice. snRNA U6 was used as internal 
control with foldchange calculated using the ΔΔCt method.  
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29.000 genes. We applied the same criteria as for miRNA microarrays data analysis: VSN method 
for normalization, p-value<0.05 and fold difference of 1.5 as cut-off. 424 genes were found 
differentially expressed in XLMTM. In this experiment outliers identified in miRNA profiling were 
not included. An additional sample, KO7, was excluded by Spearman rank correlation quality 
controls performed by Affymetrix. (Appendix Fig.5) 
 In order to determine the functional categories potentially dysregulated in XLMTM, gene 
ontology enrichment using GOstat was estimated. GOstat assigns overrepresented functional 
categories according to associated significant p-values within a set of genes. Using as primary 
entity list the previously identified 424 differentially expressed mRNAs we obtained 8 significant 
functional groups (corrected p-value<0.02). In agreement with the expected, the resulted 
categories are directly associated with the pathophysiology of myotubular myopathy. Functional 
groups related to sarcomere structure, muscle development processes and protein network 
regulation were found overrepresented.  (Appendix Table1) The muscle-specific phenotype 
characteristic of XLMTM rationalizes the data and corroborates the biological importance of 
further studies based on these genes. 
  
3.7) Identification of miRNA-target interactions  
 miRNA profiling and subsequent qRT-PCR validation revealed differential expression of  
miRNAs in Mtm1-deficient mice compared to controls, demonstrating their involvement in 
myotubular myopathy. Each of the computational miRNA target prediction tool provides hundreds 
of target genes that may be regulated by a particular miRNA. Most of those predicted target genes 
may not be regulated in all tissue types or diseases sates. Further, a larger number of false 
positives also make the identification of real targets a very tedious process.  To decipher functional 
miRNA/target gene networks in myotubular myopathy, we decided to identify significantly altered 
transcripts by mRNA profiling.  All the genes that were thus identified were then matched with the 
list of 12 significantly altered miRNAs to identify their target genes in myotubular myopathy.  
 mRNA profiling was performed in the same Wt/Mtm1 mice samples that were used for 
miRNA profiling earlier. This led us to identification of 424 transcripts that showed differential 
expression between Mtm1 and WT mice.  We next identified genes from these 424 genes that 
were a direct target of any of the 12 miRNAs that are significantly altered in Myotubular myopathy 
using Genespring.   
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 There are several computational tools that are commonly used to identify miRNA target 
genes such as Targetscan, Miranda, PicTar and MicroCosm. Genespring has Targetscan integrated 
in its module and is widely used to identify targets with high accuracy. Combing the mRNA data 
(424 genes) to identify potential 12 miRNA targets resulted in 142 direct target genes of these 
miRNAs. (Figure 6) 
 
 
 
 
 
 
 
 
 
 
Fig 6: Skematic representation of combinatorial approach used to identify significant miRNAs and their mRNA target 
genes. miRNA as well as mRNA expression profile were performed using microarrays. Statistical analysis considered 
p-values<0.05 and foldchange>1.5 cut-offs. 424 significant mRNAs were overlapped with the predicted target genes 
for the 12 identified miRNAs, using TargetScan software. The resulted matching list contains 142 genes and is 
represented in the Venn-diagram.  
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3.8) Functional categories enriched in potential miRNA-regulated genes correlates with disease 
phenotype 
The group of 142 candidate miRNA-regulated genes differentially expressed in XLMTM, 
was subsequently classified in overrepresented functional groups using GOstat. Interestingly, 
although the main categories involved in muscle development and sarcomeric composition 
overlapped the functional groups obtained for the 424 genes differentially expressed in mRNA 
expression profile, additional categories were highlighted for the same p-value<0.02. 
 Regulation of the progression through cell cycle, cardiac muscle morphogenesis and 
muscle contraction we also identified as enriched categories. (Table 5) These results are in 
conformity with previous reports suggesting the role of some of the identified miRNAs in the 
regulation of cell cycle. (Papagiannakopoulos et al., 2008) (Tryndyak et al., 2009) (Schoolmeester 
et al., 2009)  
Furthermore, due to muscle injury in XLMTM patients and mice models, the observed 
overrepresentation of cardiac genes (skeletal muscle embrionary protein isoforms) might 
represent a biological compensatory mechanism to restaure muscle integrity and homeostasis. 
This strategy was previously described for several other congenital myopathies, including 
nemaline myopathy. (Laing NG, 2007) Patients with nemaline myopathy associated with null 
mutations in the alpha-skeletal muscle actin are only able to survive due to a re-expression of 
cardiac (embryonary) actin isoform that partially compensates for the absence of alpha-actin, 
required for muscle structure and function. (Nowak et al., 2007) 
Finally, the identification of muscle contraction category is in agreement with recent 
studies that postulate myotubular myopathy results in defective excitation-contraction coupling 
due to transverse-tubules (T-tubules) structure destabilization and impaired ryanodine-mediated 
sarcomeric reticulum Ca2+ release. (Dowling et al., 2009) (Al-Qusairi et al., 2009) A deficiency in the 
production of myotubularin dysregulates the levels of phosphoinositides synthesis and 
degradation, required for proper regulation of endocytosis dynamics and membranous structures 
remodeling.  
Muscle contraction requires the transfer of action potential from the sarcollema (in 
particular from T-tubules) to the sarcoplasmic reticulum to trigger Ca2+ release and subsequent 
Ca2+ dependent signaling pathways activation. T-tubules are sarcolemma invaginations constituent 
of the triads that transmit the signal to terminal cisternae promoting the induction of Ca2+ release 
from the internal Ca2+ storage compartment sarcoplasmic reticulum to the cytoplasm through 
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RyR1 channel. As membranous structures, T-tubules function, and consequently excitation-
contraction coupling, is dependent on phosphoinositide activity regulated by PI3 kinases and 
phosphatases, such as myotubularin. (Flucher, 1992) (Frank and Oz, 1992) 
Given the described evidences of biological relevance of the functional categories 
enriched in this experiment for myotubular myopathy development, we further decided to focus 
on miRNA-regulated mRNAs differentially expressed included in these groups.   
 
 
 
 
Most significant GO 
categories 
Genes 
GO:0005515 
(Protein binding) 
ube2g2 rb1 klhl31 abcd2 tcf12 lrrc2 trim63 app bhlhb3 phka1 adssl1 
col8a1 btg2 mkl1 homer1 igfbp5 napb ablim1 csrp3 postn sorbs1 dmd 
gadd45a ranbp9 mafk flnc lrrn1 mstn jak2 tiam2 ncam1 esr1 erbb2ip 
frzb errfi1 lrrc58 mtap1b arntl atp1b2 tnni1 ctgf actc1 rasgrp3 ankrd1 
enah cnksr1 atf3 cdkn1a atp2a2 gabarapl1 tlr4 dapk1 kcnn3 runx1 
macf1 calm3 ar palld arl6ip5 calm2 fbxw7 hexa hdac4 aspn 
GO:0043292 
(Contractile fiber) 
trim63 dmd actc1 ankrd1 myoz2 tnni1 tnnt2 csrp3 
GO:0005856 
(Cytoskeleton) 
jak2 gabarapl1 ablim1 rb1 csrp3 sorbs1 dmd hspb7 app mtap1b macf1 
myoz2 tnni1 tnnt2 flnc palld actc1 eml1 enah 
GO:0005737 
(Cytoplasm) 
2610207i05rik ube2g2 oxct1 abcd2 msrb3 trim63 app adssl1 alas1 
col8a1 mkl1 homer1 egln3 h6pd napb slc25a24 ablim1 csrp3 sorbs1 
dmd ranbp9 flnc nploc4 jak2 tiam2 esr1 fmo2 cyb5r3 errfi1 hpgd 
mtap1b atp1b2 ces3 tnni1 tnnt2 actc1 rasgrp3 ankrd1 eml1 cnksr1 enah 
atp2a2 cdkn1a gabarapl1 bex2 chodl dapk1 glul nt5c2 psmd3 macf1 
myoz2 ar calm3 tfrc ak3 palld arl6ip5 calm2 hexa snf1lk fbxw7 hdac4 
atp6v1a 
GO:0007517 
(Muscle development) 
app chrna1 rb1 tnni1 tnnt2 csrp3 dmd actc1 trp63 
GO:0000074 
(Regulation of 
progression though cell 
cycle) 
app cdkn1a macf1 loh11cr2a rb1 esr1 trp63 gadd45a snf1lk 
GO:0055008 
(Cardiac muscle 
morphogenesis) 
actc1 tnni1 tnnt2 
GO:0006936 
(Muscle contraction) 
trim63 atp2a2 actc1 tnni1 tnnt2 
Table 5: Gene ontology categories and respective genes integrated for p-value <0.02 of significant genes matching 
mRNA expression profile and predicted genes of significant miRNAs. Total of 142 genes analysed. 
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Additional biological considerations were also taking into account to select genes for 
subsequent research. miRNAs negatively modulate gene expression by  leading to mRNA target 
degradation, guiding of cognate mRNAs to P bodies for subsequent inactivation or complete 
degradation or by directly repressing their translation. (Bartel, 2004; Rana, 2007) In light of this 
mode of action if a miRNA is downregulated its target gene is expect to be upregulated, and the 
opposite respectively. Following this concept we next searched for mRNA target genes that 
showed an inverse differential expression comparing to their candidate differentially expressed 
miRNAs. 
For further fine-mapping of potential important miRNA-mRNA interactions we prioritized 
genes overrepresented in common functional ontology categories and mRNA targeted by several 
miRNAs to reduce the number of false positives. (Ivanovska and Cleary, 2008; Krek et al., 2005) 
This approach promoted the exclusion of miR-337, miR-376a and their single target genes 
from the list of miRNAs/mRNAs to deeper investigate.   
The genes Ablim1, Actc1, Carp (Ankyrin 1), Cdkn1a (p21), Csrp3, Gadd45a, Jak2, Macf1, 
Mtap1b, Myoz2, Tnni1, Trim63 (Murf1), Trp63, Frzb, Hdac4, Homer 1, Igfbp5, Runx1 passed the 
described criteria and consequently were selected for subsequent analysis. In addition, a subset of 
genes differentially expressed in the mRNA expression profile that are not direct targets of 
miRNAs but are known to work in conjugation with the miRNA target genes were also included to 
identify regulatory networks operating in myotubular myopathy. (Table 6) 
 Among these Tnnt2, Rb1, Mstn, Foxo1, Fbxo32, Myog and Gas5 genes were found differentially 
expressed in XLMTM and selected based on their known role in muscle development and repair. 
(Table 7). To validate the differential expression of these genes qRT-PCR array was performed.   
qRT-PCR confirmed the results of microarray expression data in  these mice, with the exception for 
plcd4 gene. (Fig. 9) 
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Table 6: Genes selected for further studies based on mRNA expression profile and predicted target genes of significant 
miRNAs list (142 genes). TargetScan was used to identify target miRNA target genes. 
 
 
  
 
 
 
 
 
 
 
 
Gene Name Description miRNA target 
Ablim1 actin-binding LIM protein 1 miR-434-3p, mir-376c 
Actc1 actin, alpha, cardiac miR-434-3p 
Carp ankyrin repeat domain 1 (cardiac muscle) miR-431 
Cdkn1a cyclin-dependent kinase inhibitor 1A (P21) miR-379 
Csrp3 cysteine and glycine-rich protein 3 (muscle LIM protein) miR-431 
Gadd45a growth arrest and DNA-damage-inducible 45 alpha miR-489 
Jak2 Janus kinase 2 miR-541 
Macf1 microtubule-actin crosslinking factor 1 miR-431, miR-410, miR-379 
Mtap1b microtubule associated protein 1b miR-376c, miR-379 
Myoz2 Myozenin2 miR-410, miR-379 
Tnni1 troponin I, skeletal, slow 1 mir-489 
Trim63 tripartite motif-containing 63 miR-431, miR-410 
Trp63 transformation related protein 63 miR-434-3p, miR-410 
Hdac4 histone deacetylase 4 miR-127 
Homer 1 Homer homolog 1 (Drosophila) mir-410 
Igfbp5 insulin-like growth factor binding protein 5 miR-137 
Runx1 Runt related transcription factor 1 miR-541 
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3.9) Biological pathways modulated by miRNAs relevant in the etiology of XLMTM 
 
3.9.1) Muscle atrophy molecular pathways are upregulated in XLMTM 
Our studies led us to identify several miRNA target genes that play a role in musclular 
atrophy. Mtm1 knockout mice show remarkable atrophy in muscle fibers as the diseases 
progresses.  Muscular atrophy represents a decrease in myofiber size due to a negative 
imbalanced ratio of protein synthesis versus protein degradation, hence shifting towards protein 
wasting. FoxO1 is a key regulator of muscular atrophy and found to be consistently upregulated in 
this study (1.63 folds upregulated in Mtm1 mice). FoxO1 transgenic mice, overexpressing FoxO1 
also show marked muscle loss and fiber atrophy. (Kamei et al., 2004) FoxO1 is an important 
member of Akt/Pi3K signaling pathway and leads to muscle atrophy in response to decreased 
Akt/PI3K signaling. It functions by upregulation of key components of ubiquitin- proteosome 
pathway that are involved in protein breakdown and are increased during atrophy (Sandri M, 
2008) In particular, the muscle-specific E3 ubiquitin ligases Murf (also denominated Trim63) and 
Mafbx (also called Fbx032) are identified as required markers for atrophy that are activated by 
FoxO1 (Bodine et al., 2001).  We found both Muscle RING finger protein 1 (Murf1) +2.68  as well as 
Muscle atrophy F-box protein (Mafbx or Fbxo32) +3.16 were overexpressed in mutants Therefore 
our results demonstrate the involvement of FoxO1 mediated activation of Murf1 and Mafbx and 
suggest the possible implication of supressed Pi3K/Akt pathway in myotubular myopathy. 
Gene Name Description miRNA target 
Dusp4 
(MKP-2) 
dual specificity phosphatase 4 miR-434-5p 
Plcd4 phospholipase C, delta 4 miR-410 
Tnnt2 troponin T2, cardiac 
 
Rb1 retinoblastoma 1 
 
Mstn Myostatin 
 
Foxo1 forkhead box O1 
 
Myog Myogenin 
 
Fbx032 F-box protein 32 
 
Gas5 Growth arrest-specific 5 
 
Frzb Frizzled related protein 
 
Table 7: Genes selected from microarrays analysis for further studies. Potential genes involved in the pathways 
regulated by miRNAs were selected. 
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We further identified two miRNAs, miR-431 and miR-410 that are downregulated in Mtm1 
KO mice and target Murf1 which we found to be upregulated and is a crucial regulator of atrophy. 
These results suggest multiple levels of activation of muscular atrophy pathways 
dependent/independent of miRNAs. Further functional studies will provide detailed insights in to 
contribution of these miRNAs in to muscular atrophy seen in myotubular myopathy. (Figure 7) 
 
3.9.2) Structural sarcomeric proteins implicated in muscle integrity are overexpressed in XLMTM 
 
In XLMTM, integrity of myofibrillar apparatus predominates, however, Z-streaming or 
complete sarcomeric loss is often reported. Coordinate expression changes in the levels of 
structural proteins harboring the link between the sarcomere and the nucleus might be crucial 
during disease status. Different specialized compartments in the sarcomere orchestrate distinct 
proteins relevant for intracellular signalling. In M-bands predominate protein-kinase regulated 
ubiquitin signaling and protein turnover mechanisms, while I-bands and Z-disks are mainly 
constituted by stretch sensitive pathways associated with transcription factors modifiers. (Laing 
NG, 2008)  
Interestingly, we identified several structural sarcomeric proteins upregulated in Mtm1 
mice.  Conversely, miRNA targeting these structural proteins were found to be downregulated in 
diseased state. Many of these sarcomeric genes have found to be upregulated in muscular atrophy 
in other myopathies as well. ankyrin repeat domain 1 (Ankrd1 or CARP) showed in microarrays 
analysis an upregulation in mutants of +7.30. Ankrd1 is a skeletal and cardiac muscle expressed 
transcription cofactor protein known to interact with titin/connectin and myopalladin. Mutations 
in Ankrd1 were described to be associated with the development of hypertrophic 
cardiomiopathies, revealing its requirement for muscle architecture. (Moulik et al., 2009) (Arimura 
et al., 2009) Ankrd2 was also upregulated in mRNA expression profile (+2.91). Ankrd2 shares high 
levels of homology with Ankrd1 and belongs to the same muscle ankyrin repeat proteins family 
(MARP). Ankrd2 is preferentially expressed in slow muscle fibers and cardiac muscle and was 
postulated to function in cooperation with Ankrd1 in the modulation of skeletal muscle gene 
expression programming in response to signaling pathways. Marp family function is still mainly 
unknown although increasing evidences support its role in sarcomeric structure integrity and 
function in the modulation of muscle-specific gene expression in muscular pathology context, such 
as atrophy. (Barash et al., 2007) (Miller et al., 2003) Ankrd1 and Ankrd2 were also suggested to 
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induce the expression of the cell cycle inhibitor gene p21 (+4.8 upregulated in our experiment and 
present in the 142 genes list), MLP (also +3.9 upregulated in 142 entity list) and regulate the 
expression of MyoD. (Kojic et al., 2004; Laure et al., 2009)  
 Other sarcomeric proteins such as Csrp3 (cysteine and glycine-rich protein 3 or muscle LIM 
protein) showed an upregulation of +3.9 and Myozenin2 (Myoz2) an upregulation of +2.4 in 
diseases muscles. Muscle LIM protein (encoded by the csrp3 gene upregulated in XLMTM) has a 
dual role by colocalizing with Z-disks and nucleus. In the first scenario, MLP function as a linker 
scaffolding protein fundamental to muscle integrity. (Barash et al., 2005) By presenting the ability 
of translocation to the nucleus MLP is involved in muscle sensory signaling pathways and 
promotion of myogenesis in differentiating muscle cells. (Arber et al., 1994; Flick and Konieczny, 
2000) Interestingly, Csrp3 and Ankrd2 were also found upregulated in nemaline myopathy, a 
severe non-dystrophic congenital myopathy.  (Sanoudou et al., 2006) In addition, Csrp3 was found 
to be upregulated in muscle injury conditions (Barash et al., 2004) while mutations associated with 
this gene promoted hypertrophic cardiomyopathy. (Geier et al., 2008; Knoll et al., 2002) Finally, 
Myozenin 2 (or Calsarcin-1) is an additional Z-disk interacting protein known to be mutated in 
cardiac hypertrophy conditions. 
 As noted earlier many miRNAs that target these sarcomeric proteins were found to be 
downregulated in myotubular myopathy. miR-431 that targets Ankrd1 and Crsp3 is significantly 
decreased (7.31 folds) in Mtm1 mice. miR-431 also targets Murf1 another gene that is upregulated 
in muscular atrophy as discussed earlier. Similarly, miRNA 379 that is found to be down regulated 
in diseases state also have several direct targets that are upregulated in Mtm1 mice as well in 
muscle atrophy. Therefore, our work identified few miRNAs that regulate a number of muscle 
atrophy causing genes. These studies suggests that these miRNA many not be specific to 
myotubular myopathy and many be operating in a number of muscle diseases involving muscle 
atrophy. Nonetheless, overexpression of these miRNAs may downregulate the genes involved in 
muscular atrophy and slow down the muscle damage and progression of myotubular myopathy. 
(Figure 7) 
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Figure 7: Putative molecular pathways involved in muscular atrophy are postulated to be mediated by miRNA gene 
expression regulation in XLMTM. The schematic diagram presented was constructed based on differential 
expression values in microarrays experiments. Positive values (and green molecules) represent gene or miRNA 
downregulated in mutants comparing to controls, while negative values and associated red molecules illustrated 
genes or miRNAs upregulated. Green filled schematic genes represent identified potentially miRNA-regulated genes 
in the 142 gene list. White filled molecules surrounded by green line represent genes only significantly differentially 
expressed in the mRNA expression profile, present in the 424 gene list.  
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3.9.3 ) Inhibition of proliferation and induction of differentiation in satellite cells 
  
 Myogenesis requires the coordinate activation of genes responsible for cell cycle 
withdrawal and muscle lineage commitment or differentiation.  We identified a robust 
upregulation of cell cycle arrest genes as well as muscle differentiation markers in diseased 
muscles. (Figure 8) p21, a predicted target of miR-379 upregulated in XLMTM, is a cyclin-
dependent kinase inhibitor of G1 cell cycle progression that directly suppresses the activity of 
cyclin-CDK2 and cyclin-CDK4 complexes that are required for cell cycle progression. p21 expression 
is required for irreversible cell cycle exit upon myocyte differentiation. In agreement with these 
data and gene expression profile in XLMTM, retinoblastoma 1 (Rb1) and myogenin (Myog) were 
also found upregulated in this condition. Rb1 is a tumor suppressor gene that negatively regulates 
the progression from G0 through to G1 and into S phase. (De Falco et al., 2006; Mal et al., 2000) 
Rb together with myogenin (a marker of differentiation) also plays a key positive role in the 
activation of muscle specific genes during myogenesis.  Also described to promote cell cycle arrest, 
Gadd45a (growth-arrest and DNA-damage inducible 45 alpha) was shown upregulated in this 
experiment, possibly as a result of the decrease expression of its candidate negative regulator 
miR-489. 
 Additionally, the actin-binding protein 1 (ablim1) previously described as a tumor 
suppressor gene, was also detected upregulated in this experiment and is a target of miR434-3p 
and miR-376c. It will be interesting to identify if each of these miRNA acts independently or miR-
434-3p and miR-376c cooperatively regulate ablim1 expression. Downregulation of these miRNAs 
and subsequent upregulation of ablim1 in XLMTM might contribute to cell cycle exit. (Kim et al., 
1997) 
 Another upregulated protein with tumor suppressor gene function associated with 
XLMTM was dusp4, a predicted target of miR-434-5p. Dusp4 (also named MKP-2) is a dual-
specificity phosphatase of the activated MAP kinases ERK1 and ERK2, which plays an essential role 
in mitogen-regulated growth factor signal transduction. (Armes et al., 2004) Erk1/2 functions by 
phosphorylation of MAPKK in response to growth factors and/or ligand molecules. An increase in 
Dusp4 can result in a subsequent decrease in Erk1/2 activation affecting MAPK and or Akt signaling 
pathways.  These are the first studies that hint towards an involvement of MAPK signaling 
pathway in myotubular myopathy. Our hypothesis is further strengthened by a recent study in 
which inhibition of Erk1/2 kinases led to reduction of myotube size and protein content. This 
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effect of MAPK pathway on muscle growth is specific to Erk1/2 as inhibition of other MAPK 
pathways i.e. JNK or p38 did not show any affect on muscle growth (Shi et al., 2009) Further over-
expression of one of the MAPK-phosphatases, MAPK1 in soleus as well as gastrocnemeus muscles 
decreased the fiber size. These studies clearly suggest the role of MAPK signaling in skeletal 
muscle maintenance as inhibition of this signaling result in muscular atrophy. 
In addition to an increase of cell cycle inhibitors in Mtm1 KO mice we also  found an 
upregulation of several genes involved in the control of stem cell growth, particularly satellite 
cells. Muscle satellite cells account for 2-5% of the total cell population in adult skeletal muscle 
where they play a major role in muscle regeneration. Under normal conditions satellite cells are 
mitotically quiescent in the adult skeletal muscle. When activated by muscle damage, they 
proliferate, differentiate and fuse with each other or injured fibers and eventually regenerate 
mature myofibers. Importantly, a small fraction of activated satellite cells exit the cell cycle and 
return to the quiescent satellite state during muscle regeneration to maintain their number and 
regenerative capacity of muscle. Thus, normal functioning of satellite cells are indispensable for 
the integrity of skeletal muscle, and the cells themselves are an important source of cells for cell 
therapy of muscle diseases, making it valuable to clarify the molecular regulation of maintenance, 
activation/proliferation, and differentiation in satellite cells.  
 Syndecan-4, a marker of satellite cells, was seen upregulated in Mtm1 mice. Syndecan-4 
expression in adult mice is restricted to satellite cells and in particular into the quiescent 
population, suggesting its role in the maintenance of quiescent satellite cell population.. 
(Cornelison et al., 2001) Gas5 (growth arrest-specific gene 5) another marker of quiescent satellite 
cells was also found upregulated in Mtm1 mice. (Coccia et al., 1992) Trp63 (transformation related 
protein 63) that is necessary for adult stem cells maintenance was also seen to be upregulated in 
diseased muscles. (Su et al., 2009) Trp63 is a target gene of miR-410 and miR-434-3p and may be 
co-regulating by these miRNAs. We also observed a number of other satellite cell activation 
markers such as Pax3, Myf5, Eya1 downregulated in Mtm1 mice by other expression analysis. 
Furthermore, recent studies demonstrated that a reduction in frizzled levels (also downregulated 
in Mtm1 KO mice) leads to an increase in Wnt signaling pathway which consequently is associated 
with a reduction in the ability of maintenance of stem cells potential in mice. (Brack et al., 2007) 
 These observations make us hypothesize that the inability of atrophic skeletal muscle to 
respond to regenerative stimuli and promote hypertrophy might result from defective 
proliferation as well as activation of satellite cells (myogenic stem cells progenitors). In a 
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cooperative mode miR-379, miR-410, miR-434-3p, miR-434-5p, miR-376c and miR-489 might 
control the overexpression of genes that promote cell cycle arrest, as well as induce muscle 
differentiation. This suggests that a lack of cell proliferation coupled with an increase in 
differentiation proteins in Mtm1  KO mice result in only a small number of activated satellite cells, 
insufficient for proper muscle repair and constitutes one of the crucial mechanisms that ultimately 
result in muscular atrophy in Mtm1-deficient mice. The genes responsible for these pathways are 
regulated by a number of miRNAs thus forming a coordinated network where any defect in the 
circuit can elicit a response eventually leading to muscle atrophy.   
 Some of these miRNAs such as miR-379 and miR-410 show a significant contribution in 
multiple processes: cell cycle defects as well as muscular atrophy. This suggests that muscle 
atrophy is not a final manifestation of diseased muscle state but a process in which genes are 
tightly regulated from very early stages of disease.  This is clearly seen from expression of several 
muscle atrophy genes that show an increase in Mtm1 mutant mice in preclinical stage (this 
difference increases further as the disease progresses).  Therefore, over expression of miR-379 
and miR-410 in Mtm1 KO mice may lead to correct satellite cell activation as well as muscular 
atrophy defects and provides a promising potential therapeutic approach for treatment of 
myotubular myopathy. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
b
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Figure 8: Diagrams illustrating the hypothesized miRNA-mediated pathways implicated in the regulation of satellite 
cells function. a) Microarray expression of genes and potential regulator miRNAs reported to be crucial for stem cells 
maintenance. B) Microarray expression of miRNAs and cognate predicted target genes responsible for regulation of cell 
cycle. Of note, genes involved in the promotion of cell cycle arrest and promotion of cell differentiation are 
upregulated in mutants. Positive values (and green molecules) represent gene or miRNA downregulated in mutants 
comparing to controls, while negative values and associated red molecules illustrated genes or miRNAs upregulated. 
Green filled schematic genes represent identified potentially miRNA-regulated genes in the 142 gene list. White filled 
molecules surrounded by green or red line represent genes only significantly differentially expressed in the mRNA 
expression profile, present in the 424 gene list. 
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3.9.4) Overexpression of Type I myofiber genes 
An additional pathway seems to be also upregulated in XLMTM and correlate with the phenotype 
observed in individuals with myotubular myopathy. A significant overepresentation and 
upregulation of genes involved in the switch from fast to slow muscle fibers was observed.  
Troponin I, skeletal, slow 1, cysteine and glycine-rich protein 3 (muscle LIM protein), Myozenin2 
and ATPase, Ca++ transporting, cardiac muscle, slow twitch 2, Troponin T2, cardiac, were found 
significantly upregulated. (Table 8) Their inverse correlation with miRNA predicted targets suggest 
the involvement of miRNAs in regulation of this biological mechanism associated with several 
neuromuscular disorders. Further analyses in this topic are presently being developed.  
 
 
 
 
 
 
 
 
 
 
Biological Process Associated Genes 
Muscle atrophy Murf1, Mafbx, FoxO1, 
Sarcomeric integrity Ankrd1, Csrp3, Myoz2, Ankrd2 
Differentiation/ Proliferation 
Ablim1, Dusp4, Gadd45a, Igfbp5, Frzb, p21, Runx1, 
 Trp63, Rb1, Myog, Syndecan-4, Gas5 
Type I myofibers Tnni1, Myoz2, Csrp3, Tnnt2, Atp2a2 
  
Table 8: Biological pathways hypothesized to be regulated by miRNAs and disrupted in XLMTM pathology. Genes 
highlighted in bold are predicted targets of significant identified miRNAs. 
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3.10) Differential expression of  candidate miRNA-regulated genes during development 
 After the identification of potential significant miRNA-regulated pathways 
involved in the etiology of myotubular myopathy we further decided to evaluate their association 
with the progression of the pathology observed in knockout mice. Graphic X represents the 
obtained folchanges in qRT-PCR array for KO/WT gene expression of 26 selected genes in three 
developmental disease stages (14, 27 and 49 days). The expression of all genes for all stages was 
successfully achieved, with the exception of plcd4 to which signal was never observed (indicating 
the probe used was unsuitable to hybridize with our samples).  (Figure 9) 
As the results illustrate, there is a significant and consistent increase in the changes of 
expression of the identified genes during development, refecting their fundamental role in the 
development of XLMTM progression. It is striking to note that 21 out of 26 analysed genes showed 
the same pattern of differential expression in the three developmental time points verified 
(Ablim1, Actc1, Ankyrin 1, Cdkn1a, Csrp3, Gadd45a, Macf1, Mtap1b, Myoz2, Tnni1, Trim63, Trp63, 
Hdac4, Runx1, Tnnt2, Rb1, Foxo1, Fbxo32, Myog, Gas5 and Dusp4). These data suggest that 
identified overepresented pathways regulated by miRNAs do not represent experimental artifacts 
but are involved in the basis of myotubular myopathy since the assymptomatic stage (14 days).  
Interestingly, all genes that present an opposed pattern of foldchange showed a slight 
upregulation in the assymptomatic and mild disease condition stages and a significant higher 
downregulation in endstage mice. Therefore, we suggest the expression of Frzb, Igfbp5, Homer1 
and Mstn might represent a general consequence of muscle injury.  
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Figure 9: Graphic illustrating foldchange differences obtained in qRT-PCR array for 26 selected genes. For each gene, three developmental time points were evaluated: 14 days, 
27 days and 49 days. For each stage 4 WT and 4 KO samples were used. For each sample 3 technical replicates were used and the data was normalized to GAPDH expression 
values. FoldChange was calculated using ΔΔCt method. Error bars were design on excel using pattern error. 49 days mice show a significant higher difference of folchange KO/WT, 
correlating with the severity of the disease and consequently corroborating the hypothesis of the involvement of these genes in the pathology of XLMTM. 
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4) Concluding remarks 
 In the current investigation we have explored the potential role of microRNAs in X-linked 
myotubular myopathy. The relationship between miRNAs and their target genes is complex and 
available miRNA target prediction methods are still mainly imprecise. To dissect miRNA-regulated 
pathways with functional significance in the disease context, we used a microarray-based 
combinatorial approach that integrates differential expressed genes in XLMTM and in silico 
predicted targets of differentially expressed miRNAs.  
 We identified miR-127, miR-137, miR-337, miR-376a, miR-376c, miR-379, miR-410, miR-
431, miR-434-3p, miR-434-5p, miR-489 and miR-541 as strong candidate molecules to be 
implicated in these interactions.  It is interesting to remark that the expression of these miRNAs 
was never previously described in skeletal muscle. miR-337 and miR-376a target genes were, 
however, not recognized as significant in the pathophysiology of XLMTM. miRNAs are pos-
transcriptional modulators of gene expression thought to influence cell function through 
translation repression of their specific mRNA targets or promotion of mRNAs degradation. 
(Sontheimer and Carthew, 2005) (Eulalio et al., 2008) 
 Accordingly, direct effects of miRNAs in their targets genes might not be reflected at the 
mRNA level in conditions of translation repression.  miR-337 and miR-376a may be involved in 
XLMTM but not detected their target genes by  the methodology applied,  highlighting the 
importance of further studies in this field. Nonetheless this possibility, miRNAs may indirectly 
trigger a down-stream cellular feedback mechanism to promote mRNA destabilization of 
translational repressed molecules.  Moreover, miRNAs can directly promote mRNA degradation as 
well as mRNA target sequestration to P bodies for subsequent inactivation and degradation. (Wu 
and Belasco, 2008) These effects correlate with decreasing messenger RNA levels, detected in 
microarray experiments. Thus, we preferred to follow this approach to reduce false discovery 
values. 
 Ultimately, the goal of this study was to decipher how miRNA-mediated regulation of gene 
expression is associated with the disrupted molecular pathways of XLMTM. For this purpose 
functional categories enrichment for differentially expressed genes overlapping significant miRNA 
predicted genes was assessed. The functional groups muscle development, cardiac 
morphogenesis, regulation of cell cycle and muscle contraction were recognized. Further 
bioinformatic analysis with parallel experimental validation by qRT-PCR arrays of miRNAs and their 
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potential target genes enabled a comprehensive analysis of the role of identified miRNAs during 
muscle development and disease.   
 An overall analysis integrating miRNA/mRNA data allowed us to suggest potential 
significant biological pathways regulated by miRNAs that may underlie myotubular myopathy. Our 
preliminary data strongly supports the involvement of miRNAs in the regulation of muscular 
atrophy process, severely observed in this pathology, through the activation of a dependent 
FoxO1/Murf1/Fbxo32 molecular network. Furthermore, we speculate the inability of skeletal 
muscle to respond to muscle injury signaling pathways and promote regeneration might be 
associated with miRNA-regulated defects in the activation and proliferation of satellite cells, 
required for adult muscle growth and repair. (Buckingham and Montarras, 2008; Shi and Garry, 
2006)(Gangaraju and Lin, 2009) Additionally, an overexpression of type I myofiber genes was 
observed to be targeted by differentially expressed miRNAs in this study, corroborating known 
associations in the literature  that report predominance of slow fibers in XLMTM. (Pierson et al., 
2005) 
 These findings propose an intricate control of gene expression in X-linked myotubular 
myopathy both at the transcriptional and miRNA-mediated pos-transcriptional level, providing a 
foundation for future functional studies. We warrant the requirement for additional validation 
studies in human biopsies and larger sample sets as well as the possibility of other miRNAs 
discovered since this project was initiated also contributing to disease development.   
 Knockout and over-expression experiments are in progress and might give further insights 
into the regulatory interactions between miRNAs and their cognate genes and potentially 
contribute to the identification of novel therapeutic targets.  
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 Supplementary Fig. 1: miRNA microarrays data analysis using 7 WT samples and 8 KO samples. 
  a) 3D-PCA graphic exhibiting a clear preferential association of WT2 sample with the knockout samples classe. b) 
 Genespring software class prediction application through randomization of the samples and posterior inclusion in 
 specified groups includes WT2 in the class of mutants.  
Masters dissertation/ The role of microRNAs in X-Linked Myotubular Myopathy 
Mariana Fontes 
Universidade de Lisboa – Faculdade de Ciências 57 
 
a) 
b) 
 
 
 
 
 
 
 
 
 
 
  
Supplementary Fig. 2: miRNA microarray of endstage mice (49 days)  
a) Pearson correlation table shows a dramatic reduction in the values of 
linear association for wild-type 5 sample. High values of correlation 
approximate 1, while 0 represents no correlation between normalized 
samples. b) Box Whisker Plot translates the distinct pattern of 
expression of normalized wild-type 5 sample.  
Bone contamination in the collection of gastrocnemeous muscle might 
explain this discrepancy in miRNA expression profile. 
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Supplementary Fig. 3: Statistical Analysis of Microarrays (SAM) used to examine miRNA expression profile in endstage mice. 
Different tried FDR values with the respective significant genes obtained are shown. 
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Supplementary Fig 4: Dlk1-Dio3 representation from Ensembl highlighting with arrows the genomic 
location of miRNAs identified in human (has) and mouse (mmu) probes available in the miRNA 
microarray as significant (black arrow), only significant changes in mmu probes (red arrow) and only in 
hsa probes (blue arrow). All the miRNAs found only differentially expressed in hsa probes didn’t have 
the homologous probe for mmu in the chip. Moreover, BLAST search enabled to identify homology 
between significant hsa identified miRNAs and mmu miRNAs as shown in the diagram. Their possible 
involvement in the disease should consequently be addressed in further studies.  
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GO Term Corrected p-value 
Muscle development 0.017 
Myofibril 2.97E-07 
Sarcomere 8.79E-08 
Z disc 0.007760731 
I band 7.72E-06 
Contractile fiber 8.79E-08 
Protein binding 0.0030 
Cytoplasm 4.37E-04 
Supplementary Fig. 5: Spearman Rank Correlation quality control performed by Affymetrix representative 
company. This coefficient is a non-parametric measure of the correlation between two variables. Samples WT4 
and KO7 were considered potential outlier, however only KO7 was significantly considered as outlier and 
excluded for further analysis.  
Supplementary table 1: Gene ontology enriched categories for 424 
statistically significant genes, identified on mRNA expression profile 
